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Xerostomia, also known as “dry mouth,” is a common disease with reduced salivary flow. Due 
to the reduced protection functions of saliva, patients with xerostomia often have increased risk 
of oral diseases. Saliva substitutes available on the market have a short residence time in the 
oral cavity and therefore their effect is only temporary. There is a need to develop a product 
with prolonged residence time due to mucoadhesion, in the oral cavity, to provide prolonged 
relief from dry mouth. The overall aim of this thesis was to develop and produce polymer-based 
nanoparticles (NPs) for potential use in the treatment of xerostomia. 
The polysaccharides used in the thesis were negatively charged alginate and low-methoxylated 
pectin (LM-pectin) and positively charged chitosan. NPs were prepared by ionic crosslinking. 
The NPs were characterized one day after preparation according to their size, polydispersity 
index (PDI), zeta potential (ZP) and turbidity. Furthermore, the long term stability of the NPs 
was measured. Some criteria were set and had to be achieved to consider the NPs as appropriate: 
The size of the NPs should be 100 – 500 nm; the PDI should be below 0,3; the absolute value 
of ZP should be larger than 30 mV and the samples should contain no visible aggregates 
(turbidity close to 0 cm-1). A rheological method was successfully set up and used for 
investigating the interaction between the polymers and mucin or the NPs and mucin. In order 
to modify the viscosity of the nanoparticle formulation to behave similar to human saliva, the 
neutral polymer hydroxethylcellulose (HEC) was added to the nanoparticle dispersions. 
The most promising formulations were 0,05% w/w alginate NPs with the ZnCl2 to alginate ratio 
35:65 and 0,05% chitosan NPs with the tripolyphosphate to chitosan ratio 15:85 or 20:80. 
Alginate and chitosan NPs remained stable over a period of one month, whereas LM-pectin 
NPs did not meet the criteria that was set. Negative rheological synergism was observed 
between chitosan and mucin, whereas the interaction between alginate or LM-pectin and mucin 
was not verified. The most promising interaction was observed between chitosan NPs (up-
concentrated) and mucin. Namely, negative rheological synergism was calculated and a 
precipitation was observed with the naked eye. Alginate NPs also showed negative rheological 
synergism. It was impossible to verify a potential interaction between LM-pectin NPs and 
mucin probably due to the aggregation of the NPs already after up-concentration. It was 
possible to adjust the viscosity of the chitosan and alginate nanoparticle dispersions with HEC. 
Final viscosity values of the NPs mixed with HEC (1% w/w or 1,5% w/w) ranged from 2 mPas 
to 5 mPas, which was in accordance with the reported viscosity value of the whole human saliva 
(2 mPas to 10 mPas).  
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Razširjen povzetek v slovenščini 
Pri magistrski nalogi sem se ukvarjala z izdelavo polimernih nanodelcev za potencialno 
uporabo v ustni votlini za zdravljenje kserostomije. Občutek suhih ust oz. kserostomija je 
pogosto povezana s povečanim tveganjem za ustne bolezni zaradi zmanjšanega ali povsem 
odsotnega izločanja sline in negativno vpliva na življenje pacientov. Vzroki za pojav 
kserostomije so lahko jemanje nekaterih zdravil, na primer antiholinergikov, Sjögrenov 
sindrom (kronična avtoimuna vnetna bolezen s progresivno limfocitno infiltracijo žlez slinavk 
in solznih žlez), ionizacijsko sevanje pri bolnikih z rakom v predelu glave in vratu ali bolezni 
vezivnega tkiva. Slina ima v ustih pomembno vlogo pri procesiranju in požiranju hrane, 
čiščenju ustne votline, vzdrževanju nevtralnega pH in preprečevanju demineralizacije zob. 
Proteini, ki se nahajajo v slini, vlažijo in pokrivajo ustna tkiva in varujejo ustno sluznico pred 
kemijskimi, mikrobiološkimi in fizičnimi poškodbami. Pacienti s kserostomijo imajo 
posledično težave pri požiranju suhe hrane in govorjenju, spremenjen okus, povečan vnos 
tekočine in neprijeten občutek v ustih ponoči. Pojavijo se lahko razpokane ustnice in jezik, 
razpoke v ustnih kotičkih, povečan dentalni karies, erozija zob, otekanje žlez slinavk, mukozitis 
(vnetje sluznice v ustni votlini), ustna kandidaza in razjede. Pacientom so na voljo različni 
pripravki za zdravljenje kserostomije: 1) zdravila, ki stimulirajo izločanje sline (npr. pilokarpin) 
2) nadomestki sline (ustna voda, pastile, spreji, geli, žvečilni gumiji). Slednji imajo zaradi 
dinamične narave ustne votline in morda tudi zaradi odsotnosti mukoadhezivnih lastnosti kratek 
čas zadrževanja na ustni sluznici in tako zagotavljajo le začasno lajšanje simptomov 
kserostomije. Glavna prednost polimernih nanodelcev pri zdravljenju simptomov kserostomije 
je podaljšan čas zadrževanja na ustni sluznici zaradi interakcije z mucinom, kar lahko zmanjša 
pogostost odmerjanja in poveča sodelovanje bolnikov pri zdravljenju poleg tega pa s 
prekrivanjem površine ustne sluznice ustvarjajo tudi fizično zaščito. Polimerni nanodelci se 
lahko vgradijo v običajne farmacevtske oblike kot sta na primer ustna voda ali sprej. 
Namen magistrske naloge je razdeljen na tri dele: 1) pripraviti stabilne polimerne nanodelce, 2) 
raziskati interakcije med nanodelci in mucinom z reološko metodo in 3) spreminjati viskoznost 
disperzije polimernih nanodelcev z nevtralnim polimerom (hidroksietilceluloza) z namenom 
doseganja viskoznosti disperzije nanodelcev, podobni človeški slini. 
Za pripravo nanodelcev smo uporabili polisaharide naravnega izvora, sestavljene iz 
monosaharidnih enot, ki so med seboj povezane z glikozidnimi vezmi. Polimera alginat in LM-
pektin sta pri fizioloških pogojih negativno nabita, hitosan pa je polikation. So stabilni, 
netoksični, hidrofilni, mukoadhezivni in biorazgradljivi ter zato primerni za pripravo 
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nanodelcev. Pripravili smo jih z metodo ionskega premreževanja. V raztopino polimera 
(alginat, pektin ali hitosan) v 0,05 M NaCl smo enakomerno kapljali raztopino premreževala 
(cinkov klorid ali tripolifosfat). Spreminjali smo masno razmerje premreževal in polimera ter 
koncentracijo polimera. Nanodelcem smo nato en dan po pripravi vrednotili velikost, 
polidisperzni indeks, zeta potencial in motnost. Spremljali smo tudi stabilnost nanodelcev skozi 
čas. Pojav agregatov je bil vizualni znak za nestabilnost vzorca. Da so nanodelci primerni, 
morajo ustrezati kriteriju, ki je bil postavljen: velikost nanodelcev mora biti med 100 in 500 
nm; polidisperzni indeks mora biti manjši od 0,3; absolutna vrednost zeta potenciala mora biti 
večja od 30 mV; v vzorcih ne sme biti opaznih agregatov (motnost mora biti blizu 0 cm-1). 
Najprej smo pripravili nanodelce s koncentracijo polimera 0,05 % w/w, z različnimi masnimi 
razmerji premreževal in polimera. Za najboljše formulacije nanodelcev so se izkazale naslednje: 
a) nanodelci iz alginata (0,05 % w/w), z razmerjem ZnCl2 : alginat = 35:65; b) nanodelci iz 
hitosana (0,05% w/w), z razmerjem TPP : hitosan = 15:85 ali 20:80. Nanodelci iz alginata in 
hitosana so ostali stabilni en mesec, medtem ko je velikost nanodelcev iz LM-pektina že po 
dveh tednih narasla preko 700 nm.  
Interakcijo med nanodelci in mucinom smo ovrednotili z reološkim sinergizmom. V literaturi 
so poročali o študijah, kjer so z reološkimi metodami določali interakcijo med različnimi 
polimeri in mucinom, vendar pristop ni bil standardiziran, zato je rezultate različnih študij težko 
primerjati med seboj. Študij, kjer bi z reološkimi metodami vrednotili interakcijo med nanodelci 
in mucinom, v literaturi ni. Reološki sinergizem izračunamo s formulo Δƞ = ƞmix - (ƞm+ ƞp), kjer 
je Δƞ reološki sinergizem, ƞmix je viskoznost raztopine polimera (oz. nanodelcev) in mucina, ƞm 
je viskoznost raztopine mucina in ƞp viskoznost raztopine polimera (oz. nanodelcev). 
Viskoznosti ƞmix, ƞm and ƞp morajo biti izmerjene pri enakih pogojih (koncentracija mucina in 
polimera oz. nanodelcev, temperatura, strižna hitrost). Metoda lahko razlikuje med pozitivnim 
in negativnim sinergizmom, ali pa je sinergizem 0, kar pomeni, da v sistemu ni interakcije. Za 
določitev parametrov metode (koncentracije polimera in mucina, topilo, strižna hitrost), smo 
najprej izmerili viskoznost raztopin z različnimi koncentracijami alginata v 5 mM fosfatnem 
pufru in 0,05 M NaCl. Rezultati pri strižni hitrosti med 0,1 in 10,0 1/s niso bili ponovljivi 
(intervali napak so bili zelo veliki), zato smo se odločili, da bomo viskoznost merili pri strižni 
hitrosti med 10 in 100 1/s. Izmerili smo tudi viskoznost raztopin mucina z različnimi 
koncentracijami v 5 mM fosfatnem pufru, 0,05 M NaCl in »kombiniranem« topilu z razmerjem 
5 mM fosfatni pufer : 0,05 M NaCl = 1:1 pri strižni hitrosti 10 – 100 1/s. Glede na rezultate 
smo za nadaljnje reološke eksperimente izbrali koncentracijo polimera 0,5% w/w v 0,05 M 
NaCl, koncentracija mucina v kombiniranem topilu pa je bila 0,25% w/w. Najprej smo 
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izračunali reološki sinergizem za interakcijo med različnimi polimeri (alginat, LM-pektin, 
hitosan) in mucinom. Raztopina hitosana je po dodatku mucina postala motna. Ob tem smo 
izračunali negativen reološki sinergizem (-0,0028 Pas). Oboje, vizualna sprememba in 
negativen reološki sinergizem, nakazujeta na interakcijo med hitosanom in mucinom. Vrednosti 
reološkega sinergizma za vzorca, ki sta vsebovala alginat oz. LM-pektin in mucin sta bili blizu 
vrednosti 0 Pas. Interakcije v tem primeru nismo dokazali.  
Koncentracija pripravljenih nanodelcev v raztopini (0,05% w/w) je bila za merjenje viskoznosti 
prenizka, saj je bil mucin s koncentracijo 0,25% w/w v presežku, poleg tega pa se je že tako 
nizka koncentracija po dodatku raztopine mucina še zmanjšala. Pripravili smo nanodelce z višjo 
koncentracijo (0,07% w/w) in jih še dodatno skoncentrirali z uporabo ravnotežne dialize. 
Nanodelce iz hitosana in alginata smo uspešno skoncentrirali. Izračunan reološki sinergizem je 
bil v obeh primerih negativen (-0,0009 Pas pri nanodelcih iz hitosana in -0,0004 Pas pri 
alginatnih nanodelcih), kar nakazuje na potencialno interakcijo med nanodelci in mucinom. 
Poleg tega smo pri nanodelcih iz hitosana s prostim očesom opazili tudi agregacijo na dnu viale, 
kar lahko potrdi interakcijo. Pri koncentriranju nanodelcev iz LM-pektina je med dializo prišlo 
do agregacije nanodelcev, zato rezultati reološkega sinergizma za interakcijo nanodelcev iz 
LM-pektina z mucinom niso uporabni. 
Najboljšim formulacijam nanodelcev iz hitosana, alginata in LM-pektina s koncentracijo 0,05% 
w/w smo izmerili viskoznost, ki je bila v območju 0,8 – 0,9 mPas. Cilj je bil pripraviti stabilno 
disperzijo nanodelcev z viskoznostjo, podobno viskoznosti človeške sline (2 – 10 mPas). 
Izmerili smo viskoznost raztopin hidroksietilceluloze s tremi različnimi koncentracijami (0,5% 
w/w, 1,0% w/w in 1,5% w/w) pri strižni hitrosti 0,1 – 100 1/s. Pred dodatkom raztopine 
hidroksietilceluloze je bilo nanodelce potrebno skoncentrirati. Končna koncentracija 
nanodelcev v raztopini je bila 0,05% w/w, hidroksietilceluloze pa 0,5% w/w, 1,0% w/w ali 
1,5% w/w. Končna viskoznost disperzij nanodelcev iz hitosana in alginata po dodatku 
hidroksietilceluloze  (1% w/w ali 1,5% w/w) je bila v območju 2 mPas do 5 mPas, kar nakazuje 
na uspešno spreminjanje viskoznosti disperzije nanodelcev in doseganje viskoznosti, podobni 
človeški slini. Pri koncentriranju nanodelcev iz LM-pektina je prišlo do agregacije nanodelcev, 
zato rezultati viskoznosti raztopine po dodatku hidroksietilceluloze niso bili uporabni. Za 
primerjavo smo izmerili tudi viskoznost produkta Biotène®, ki prav tako vsebuje 
hidroksietilcelulozo in se uporablja kot nadomestek sline. Viskoznost produkta Biotène® je bila 
10 mPas in konstantna v celotnem območju merjenja, kar je v nasprotju z viskoznostjo disperzij 
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Xerostomia is the subjective experience of a dry mouth. It is not just the uncomfortable feeling 
of dryness in the oral cavity, but it is usually associated with increased risk of oral diseases due 
to decreased or absence of saliva flow. Despite that this condition is not life-threatening, it may 
have a negative impact on the quality of patient’s life. The prevalence of xerostomia ranges 
from 10 to 46 %, based on a systematic review by Hopcraft et al. (2010), with a higher 
prevalence for women (1). It can affect people of all ages, but with an ageing population, dry 
mouth may become a greater problem in the future (2). 
Saliva is formed by the three paired major salivary glands (parotid, submandibular and 
sublingual) as well as hundreds of minor salivary glands. Production of saliva is controlled by 
both the parasympathetic and sympathetic nervous systems, where the parasympathetic 
stimulation is more important and the sympathetic effects are smaller. Therefore, saliva 
secretion is increased due to the activation of the parasympathetic nervous system by food in 
the mouth or smells and decreased due to the inhibition of the parasympathetic nervous system 
by sleep, dehydration, fear and anticholinergic drugs (3). 
1.1.1 Causes of xerostomia 
Dry mouth is a frequent side effect of many commonly prescribed drugs such as 
anticholinergics, antihypertensives, etc. Sjögren’s syndrome is a chronical systemic 
autoimmune inflammatory disease with a progressive lymphocyte infiltration of the exocrine 
glands, especially the salivary and the lacrimal glands. It can occur independently as a primary 
Sjögren’s syndrome (it affects only salivary and lacrimal glands) or as a secondary Sjögren’s 
syndrome (together with any other autoimmune disease) (4). Ionizing radiation in cancer 
patients who need radiotherapy as a primary, concomitant or adjuvant treatment for the tumors 
in the head and neck region can injure the major and the minor salivary glands which can lead 
to different degrees of temporary or permanent xerostomia (5). Most common causes of 







Table I – Most common causes of xerostomia 
 
Medications 
Anticholinergics, Antidepressants, Antipsychotics, Diuretics, 




Primary and secondary 
Connective tissue 
diseases 
Rheumatoid arthritis, Systemic lupus erythematosus, Systemic sclerosis, 
Mixed connective tissue disease 
 
Other conditions 
Radiation therapy, Primary biliary cirrhosis, Vasculitis, Chronic Active 
Hepatitis, HIV, AIDS, Bone marrow transplantation, Graft vs. host 
disease, Renal Dialysis, Anxiety, Depression, Diabetes type 1 and 2 
1.1.2 The consequences of xerostomia 
In order to understand the consequences of xerostomia, the function of saliva needs to be 
explained. Saliva has a big role in digestion and provides several protective functions. It cleans 
the oral cavity, relieves oral processing and swallowing of food, maintains a neutral pH in the 
oral cavity and prevents demineralization of the teeth. Salivary proteins lubricate and cover the 
oral tissues and protect the oral mucosa from chemical, microbial and physical injuries. 
Moisture to facilitate speech and taste is also provided by saliva (6, 7). Consequently, patients 
with xerostomia experience difficulties while swallowing and chewing dry food, altered taste 
sensations (dysgeusia) and speech difficulties. They have increased liquid intake and feel a 
discomfort during the night. Signs that can be noticed are dry and cracked lips and tongue, 
cracks in the corners of the mouth, increased dental caries, tooth erosion, swelling of the 
salivary gland, erythematous tongue, mucositis, oral candidiasis and ulcers (2). 
1.1.3 The management of xerostomia 
After xerostomia is diagnosed, the patient needs to be educated about potential complications 
and the importance of the regular oral hygiene. Patients with xerostomia require more recurrent 
dentist visits and maintain adequate hydration by sipping water, keeping an ice cube in the 
mouth or using a humidifier during sleep. The fluoride dentifrices are also recommended, 
because they can effectively reduce occurrence of caries and are generally well tolerated by 
patients. Patients with candidiasis must be treated with topical antifungal agents or systemic 
when needed. Products for the treatment of xerostomia available on the market are divided in 
two: 1) salivary stimulants and 2) salivary substitutes. Some of the products used for treatment 
of xerostomia that are available on the Slovenian market can be found in table II. Salivary 
stimulants, for example pilocarpine, can increase salivary output, but patients with more 
severely damaged salivary glands may not have a good response to the treatment. Also, the 
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adverse effects such as sweating, nausea and rhinitis can occur. There are also various products 
(rinses, lozenges, sprays, gels, chewing gums) which are believed to substitute the saliva. They 
do not have the protective functions as saliva. Due to the dynamic nature of the oral cavity 
salivary substitutes are removed when swallowing or perhaps they do not possess mucoadhesive 
properties. Therefore, they have a short residence time and provide only temporary relief from 
dry mouth (2, 6). In a Cochrane review (2011) authors concluded there is no strong evidence 
that any topical therapy is effective for relieving the symptom of dry mouth (8).  
Table II – Some of the products used for treatment of dry mouth on the Slovenian market 
Product Pharmaceutical form Active ingredients  Other ingredients 
Salagen® 5 mg 
(9) 
 
film-coated tablets Pilocarpine 
hydrochloride 
Microcrystalline cellulose, Stearic acid, 
Opadry white OY-7300 (containing 
Hypromellose, Macrogol 400 and 
Titanium dioxide), Carnauba wax 
Glandosane 
(10) 








Sodium benzoate, Sorbic acid 
Xerostom (11) Oral spray Xylitol, Glycerin, 
Calcium lactate 
Aqua, PEG-40 Hyrogenated castor oil, 
Betaine, Extra virgin olive oil, Propylene 
glycol, Tocopheryl aceate (Provitamin E), 
Panthenol (Provitamin B5), Parsley oil, 
Aroma, Allantoin, Lactic acid, Sodium 
methylparaben, Sodium propylparaben, 
Diazolidinyl urea, D-limonene.  
Xerostom (12) Dental gum Xylitol, Maltitol, 
Glycerin 
Gum base, Aroma, Betaine, Acacia 
senegal gum extract, Lecithin, Titanium 
dioxide, Calcium pantothenate, Olea 
europea oil, Carum petroselinum oil, 
Shellac, Carauba wax. 
Xerostom (13) Toothpaste Glycerin, Xylitol, 
Sodium fluoride 
Aqua, Hydrated silica, Betaine, 
Tetrapotassium pyrophosphate, Extra 
virgin olive oil, Xanthan gum, Titanium 
dioxide, Tocopheryl acetate (Protivamin 
E), Panthenol (Provitamin B5), Parsley oil, 
Aroma, Potassium phosphate, Papain, 
Diazolidinyl urea, D-Limonene. 
Xerostom (14) gel Glycerin, Xylitol Demineralised water, Tripotassium citrate, 
Betaine, Tetrapotassium pyrophosphate, 
Extra virgin olive oil, Calcium lactate, 
Xanthan gum, Aroma, Potassium 
phosphate, Sodium benzoate, Provitamin 
B5, Provitamin E, Parsley oil, Sodium 
propylparaben 
Xerostom (15) Lozenge Mannitol, Xylitol, 
Sodium fluoride  
Magnesium stearate, Aroma, Betaine, 
Papain, Calcium pantothenate, Olive 
extract, Parsley extract 
Miradent 
Aquamed (16) 
Lozenge  Xylitol, Calcium lactate, 
Lysozyme 
Gummi arabicum, Magnesium stearate, 
Malic acid, Aroma 
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1.2 Environment of the oral cavity 
The oral cavity (mouth) includes teeth, gingiva (gum), hard and soft palate, cheek, tongue, lips 
and the floor of the mouth as illustrated in figure 1. The inside of the oral cavity is covered by 
a mucous membrane which consists of 40 – 50 layers of epithelial cells. Saliva constantly 
washes the surface of the mucous membrane and is composed mainly of water (99%) and other 
substances such as electrolytes, immunoglobulin, enzymes, mucins and urea (17). The oral 
cavity has a surface area of approximately 100 cm2, temperature ranges from 32 to 37 °C and 
average pH is 6,8. It has a high degree of vascularization and a large surface-area-to-volume 
ratio (18). 
 
Figure 1 – The anatomy of the oral cavity 
1.2.1 Mucus and mucoadhesion 
The mucus is a gel layer attached to the mucosa and is composed of water (approx. 95%), mucin 
glycoproteins and lipids (0,5 – 5%), inorganic salts (0,5 – 1%) and free proteins (1%). It has 
different roles such as lubrication, maintaining the hydrated layer and also acts as a barrier 
between the oral environment and the epithelial cells (19).  
The mucins are a family of glycoproteins characterized by their high molecular weight (1000 
to 40000 kDa) and are hydrophilic. Mucins can be divided into two groups – soluble and 
membrane-bound mucins. Since mucins have a protein backbone with side oligosaccharide 
chains, they are stiff and extended polymers. The negative charge is associated with sialic acid 
which is often a terminal group of oligosaccharide chains (19, 20). On the other hand, there are 
also positively charged patches in the nonglycosylated regions of mucin due to histidine, 
arginine and lysine (20).  
Bioadhesion is the ability of a material to adhere to a biological substrate. When mucus (or 
epithelial surface) represents a biological substrate and a natural or synthetic macromolecule is 
attached to it, a proper term is mucoadhesion. To achieve the formation of the bond between a 
mucous membrane and mucoadhesive material, for example a polysaccharide, three stages are 
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needed. 1) The contact stage which is achieved by placing a mucoadhesive material in direct 
contact with the mucous membrane, 2) The interpenetration stage which is interdiffusion of the 
polymers into the mucus layer, 3) The consolidation stage which includes the formation of 
mechanical and/or chemical interaction. There are five different chemical bonds that can be 
formed in the consolidation stage: Ionic, covalent, hydrogen, van der Waals or hydrophobic 
bonds (19).  
1.3 Polysaccharide based nanoparticles for local administration into the 
oral cavity 
There is a need to develop an appropriate and efficient therapy which can be used in the 
treatment of the xerostomia. The complex and dynamic environment of the oral cavity has 
already been described in the beginning of this chapter. The short residence time due to saliva 
clearance, swallowing, movements of the tongue and jaw are common problems of the products 
already on the market. Nanosystems include liposomes, nanocapsules, nanocrystals, nanofibers 
and polymeric nanoparticles (NPs). They have previously been studied for drug delivery in the 
oral cavity (21). In this work the focus will be put on polysaccharide-based NPs. There are few 
studies that have investigated formulations of polysaccharide-based NPs for local 
administration into the oral cavity and their interaction with mucin (21, 22, 23, 24, 25, 26). The 
main advantage of polysaccharide-based NPs is the potential of prolonged retention time due 
to their interaction with the mucin. This could lead to reduced dosage frequency, improved 
patient compliance and provide prolonged relief of the dry mouth (25). They could be 
incorporated in conventional administration forms, for example mouthwashes or oral sprays. 
Furthermore, polysaccharide-based NPs could provide physical protection when covering the 
oral surfaces (26). 
1.4 Polysaccharides 
Polysaccharides are polymeric long-chained carbohydrate molecules composed of repeating 
monosaccharide units bound together by glycosidic linkages. The structure of the chains is 
linear or branched. Polysaccharides have many reactive groups, a wide range of molecular 
weight and different chemical composition, which results in their variety in structure and 
characteristics. Polysaccharides are stable, non-toxic, safe, hydrophilic and biodegradable (25). 
Many of the polysaccharides are also present at the GRAS (Generally recognized as safe) list 
made by the Food and Drug administration of US (27). Having hydrophilic groups such as 
hydroxyl, carboxyl and amino groups enables polysaccharides to form non-covalent bonds with 
biological tissues, for example mucous membrane in the oral cavity. NPs made of bioadhesive 
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polysaccharides can extend the residence time in the oral cavity (28). Negatively charged 
alginate and LM-pectin and positively charged chitosan were used in this thesis.  
1.4.1 Alginate 
Alginate is an inexpensive non-toxic polymer and therefore commonly used in food, cosmetics 
and as an excipient in pharmaceutical industry. It is a natural polymer obtained from brown 
seaweed (Phaeophyceae). Alginate is 
composed of (1,4)-linked negatively charged 
blocks of D-mannuronic acid (M) and L-
guluronic acid (G). The chemical structure 
can be seen in figure 2.  
The content of G and M depends on the source 
of alginate and is stated by the manufacturer. Alginate has an ability to form two different types 
of gels, high-viscosity “acid gel” and ionotropic gel. The first is formed due to intermolecular 
binding at low pH when alginic acid is protonated due to its pKa value of around 3 - 4 (29). 
Ionotropic gelation occurs when alginate’s negatively charged residues form ionic bonds with 
divalent or multivalent cations such as calcium or zinc which acts as crosslinkers between 
alginate chains. If alginate contains higher amount of G, it leads to the formation of stronger 
gels, because G exhibit more affinity for divalent cations compared to M (22, 30). 
1.4.2 Pectin  
Pectin is a non-toxic and low-cost natural polymer obtained from apple and citrus peel, widely 
used as a thickening agent in the food industry. It is mainly composed of D-galacturonic acid 
units with different degrees of methylesterified 
carboxyl groups. The pKa value of pectin is around 
3,5 (31).  Depending on the degree of esterification 
(DE), pectin can be divided in high-methoxylated 
pectin (HM-pectin) with a DE > 50% and low-
methoxylated pectin (LM-pectin) with a DE < 
50%. Additionally, LM-pectin can be amidated, 
resulting in amidated low-methoxylated pectin 
(AM-pectin). In figure 3 the chemical structure of LM-pectin and AM-pectin is presented. LM-
pectin was used in the experimental part of this thesis due to its ability to form ionotropic gel 
(32).  
Figure 2 – Chemical structure of alginate 
Figure 3 – Chemical structure of LM-




Chitosan has already been studied for use in many different drug formulations such as gels, 
tablets, capsules and NPs (33). It is a semi-synthetic biopolymer obtained by deacetylation of 
the natural polysaccharide chitin. Chitosan consists of β-1,4-linked glucosamine and N-acetyl-
D-glucosamine units which can be seen in figure 4. The degree of deacetylation (DDA) usually 
varies from 70 to 95%, while the molecular weight ranges from 10 to 1000 kDa (24). The pKa 
value was reported to be 6,3 - 6,4 (34). The amine groups are protonated below this value and 
therefore chitosan is soluble in acidic environment. The use of acidic solvents can be avoided 




1.5 Preparation of polysaccharide-based nanoparticles 
NPs are particles with size from 1 to 1000 nm and different shapes (25). NPs can entrap or 
adsorb drugs or biomolecules and therefore have been widely studied for drug delivery. 
Polysaccharide-based NPs are prepared manly by four mechanisms: covalent crosslinking, 
ionic crosslinking, polyelectrolyte complexation, self-assembly of hydrophobically modified 
polysaccharides (28). NPs are usually unstable in suspension so they can be freeze-dried to 
extend their shelf-life and then resuspended in a proper medium before use. Their shelf-life can 
be extended with spray-drying (36). 
1.5.1 Ionic crosslinking 
The key advantages of ionic crosslinking, also called ionotropic gelation, are mild preparation 
conditions and simple experimental procedure. NPs are formed when polyanions and 
polycations or divalent ions, which act as crosslinkers, are added dropwise to polycationic and 
polyanionic polysaccharides (28). For example, NPs based on alginate can be prepared by 
crosslinking the ionized carboxyl groups on the alginate chains with Ca2+ ions in aqueous media. 
Also, other positively charged divalent ions, such as Zn2+, can act as a crosslinker (22). Not 
only ionic bonds, but also hydrogen bonds and hydrophobic interactions contribute to the 
formation of NPs. Scheme of the nanoparticle ionic crosslinking can be seen in figure 5. In 
order to form NPs instead of a macroscopic gel, the polymer concentration must be lower than 
Figure 4 – Chemical structure of chitosan 
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the overlap concentration so that the local gelation of coils of polymeric chains is promoted (22, 
35). 
 
Figure 5 – Ionic crosslinking of polysaccharide polymer and crosslinker with opposite charge 
1.5.2 Crosslinkers 
Tripolyphosphate (TPP) is the most widely used crosslinker for preparation of chitosan NPs. 
The structure of TPP can be seen in figure 6. It has negative charge over a wide pH range so it 
can interact with positively charged amine groups of 
chitosan. Ca2+ ions are mainly used as a crosslinker 
for preparation of alginate and pectin NPs, but Zn2+ is 
more advantageous for formulations used in oral 
cavity due to its antibacterial properties and inhibitory 
effect on plaque formation (37).  
1.6 Nanoparticle characterization 
1.6.1 Dynamic light scattering 
Dynamic light scattering (DLS), also called photon correlation spectroscopy (PCS), can 
measure size and polydispersity index (PDI) which is a measure of the size distributions of the 
particles in the submicron region. The technique is non-invasive and a small amount of the 
sample is needed. The principle of DLS is based on Brownian motion, a random movement of 
the particles in dispersion due to collision with the molecules of the liquid. Small particles move 
faster than larger particles. The relationship between the size and speed of the particles is 
defined in the Stokes-Einstein equation (equation 1), where D is particle diffusion’s coefficient, 
k is the Boltzmann constant, T is the temperature, η is the viscosity of the solvent and R is 
hydrodynamic radius. The hydrodynamic radius is the radius of a hypothetical hard sphere that 
diffuses at the same speed as the particle being measured and that is dependent on ionic strength, 
surface structure and shape.  







Equation 1 – Stokes-Einstein equation 
The sample is illuminated by a light source (a laser) and the instrument (Zetasizer) detects the 
rate of the intensity fluctuations in the scattered light. The measured data is the correlation curve 
which includes all of the information about the diffusion of the particles. When the correlation 
curve is fitted to an exponential function, the diffusion coefficient can be derived and then the 
hydrodynamic radius is calculated by using the Stokes-Einstein equation (38, 39). Figure 7 
represents the whole procedure starting from illuminating the sample with laser to the final size 
distribution.  
 
Figure 7 – From illuminating the sample with laser to the size distribution, taken from Malvern 
Instruments 
In figure 8, an illustration of a DLS instrument 
can be seen. It includes a laser (1) which 
provides a light source to illuminate the 
particles in the sample in the cell (2), attenuator 
(4) which is needed to reduce the intensity of the 
laser (if too much light is detected then the 
detector is overloaded), a detector (3) which 
detects the intensity of scattered light and sends 
it to a correlator (5) and computer (6) where 
derived information from the correlator is 
analyzed and the size information is displayed 
in the Zetasizer software (38).  




The detector position in the Zetasizer used in this thesis was 173° which is known as a 
technology called NIBS (Non-Invasive Back-Scatter). In comparison to the systems that have 
90° detection optics, there are several advantages: Laser beam does not need to pass through 
the entire sample and therefore higher concentrations of sample can be measured, effect known 
as multiple scattering (when light from one particle is scattered by other particles) is less, effect 
of dust is smaller, because large particles mainly scatter in the forward direction (38).  
1.6.2 Zeta potential 
Zeta potential (ZP) is the measure of the surface 
charge of the particles. If all the particles in the 
dispersion have a large negative or positive ZP, 
then they will repel each other and there is small 
probability of flocculation. Particles having ZP 
more than +30 mV or less than -30 mV are 
considered as stable (38). The zeta potential is 
schematically presented in figure 9. The inner 
region is the Stern layer and ions there are 
firmly bound. The outer layer is a diffuse layer 
having ions less strongly attached. Within the 
diffuse layer there is a theoretical boundary 
called the slipping plane. When a particle 
moves, ions inside the boundary move with it, but ions outside the boundary do not move with 
the particle. The potential at this boundary is known as the ZP (38). The instrument measures 







Equation 2 – Henry equation 
1.6.3 Turbidity measurements 
Turbidity is a measure of the degree to which the water loses its transparency due to the presence 
of NPs. The number and the size of the particles and the difference in the refractive index 
between the NPs and the solvent affects the turbidity. A spectrophotometer measures the 
Figure 9 – Layers of the NPs surface, 




 – electrophoretic mobility 
ε – dielectric constant of the solvent 
ζ – zeta potential 
f (Ka) – Henrys function (The Smoluchowski 
approximation to Henry’s function f (Ka) = 1,5 was used) 
η – solution’s viscosity 
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transmitted light intensity and the turbidity can be calculated using the Lambert-Beer’s law, 









Equation 3 – Lambert-Beer’s law  
Turbidity of the nanoparticle dispersion is close to 0 cm-1, but when turbidity is increased, the 
presence of large particles, aggregates or sedimentation is assumed.  
1.7 Rheological tests to assess mucoadhesive properties 
In general, there are two different approaches to test mucoadhesive properties, molecular scale 
testing of mucoadhesion such as spectroscopic studies (atomic force microscopy, scattering 
techniques – small angle X-ray scattering, small angle neutron scattering, static and dynamic 
light scattering) and macroscale testing of mucoadhesion such as rheological tests, inclined 
plane and tensile testing (20).  
In this thesis rheological tests were performed. The rheological tests investigate the changes in 
rheological properties of the mucoadhesive polymer when mixed with mucus or mucins. The 
method is based on the idea that the mixture of mucoadhesive polymer and mucin is 
characterized by a synergistic increase or decrease in viscosity with respect to the viscosity of 
both polymer solution and mucin dispersion (19). Hassan and Gallo suggested that rheological 
synergism can be simply calculated using viscosity values measured at a prefixed shear rate 
which can be seen at equation 4 where Δƞ is the rheological synergism, ƞmix is the viscosity of 
the polymer and mucin mixture, ƞm is the viscosity of the mucin solution and ƞp is the viscosity 
of the polymer solution. For equation 4 to be valid, ƞmix, ƞm and ƞp should be measured at the 
same concentration, temperature, time and shear rate (40). This method could distinguish 
between positive rheological synergism (interaction), lack of rheological synergism (no 
interaction) or negative rheological synergism. Sometimes different outcomes have been 
observed for the same polymer-mucin mixture due to different experimental conditions (20).  
Δƞ = ƞmix - (ƞm+ ƞp) 
Equation 4 – Rheological synergism 
Both freshly prepared and commercial mucin can be used as biological substrates. Fresh mucins 
can exhibit a high variability and can give more variable results. On the other side, commercial 
mucins show lower variability and therefore results are more reliable (19, 20).  
L – the light path length in the sample cell (1 cm) 
I
t 
– the intensity of the light transmitted through the sample 
I
0
 – intensity of the light transmitted through the solvent (water) 
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1.7.1 Viscosity measurements  
1.7.1.1 The theory behind 
Viscosity is the resistance of a fluid to the imposed shearing force and therefore viscosity values 
are not constant values because they are affected by many different conditions. Flow behavior 
can be given in two types of diagrams: (1) Flow curves with shear stress τ on the y-axis and 
shear rate γ on the x-axis, (2) Viscosity curves with viscosity η on the y-axis and shear rate γ 






Equation 5 – Law of viscosity 
There are three main flow behaviors 
known, all show in figure 10: (1) Ideally 
viscous flow behavior also known as 
Newtonian flow behavior, (2) shear 
thinning also called pseudoplastic flow 
behavior and (3) shear-thickening flow 
behavior also known as dilatant flow 
behavior (41). Most polymers exhibit 
shear-thinning behavior. At rest their long 
molecules of uncrosslinked polymers 
become contracted and form balls, because the chains become entangled with each other. Under 
shear those entangled balls become ellipsoid and molecules are disentangled. Since entangled 
structures have more resistance than individual molecules, the result is shear-thinning behavior 
with decreased viscosity at higher shear rates (41). Figure 11 presents the viscosity function of 
a polymer displaying three stages on a double logarithmic scale: (1) the first Newtonian range 
with the plateau value of the zero-shear viscosity 𝜂0, (2) the shear-thinning range with the shear 
rate-dependent viscosity function 𝜂 = f (𝛾) and (3) the second Newtonian range with the plateau 
value of the infinite-shear viscosity 𝜂∞. If a concentration of a polymer solution is too low to 
form entanglements, infinite-shear viscosity 𝜂∞ is measured in the whole shear-rate interval 
(42). 
Figure 10 – Flow curve (left) and viscosity curve 
(right) for three different flow behaviors: (1) 
Ideally viscous flow behavior, (2) shear thinning 
flow behavior and (3) shear-thickening flow 
behavior, taken from Mezger  
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1.7.1.2 Instrumentation  
The rheometer Physica MCR 301 was used for all 
the experiments in this thesis. Figure 12 shows the 
elements of the rheometer: (1) Measuring head, (2) 
measuring system coupling, (3) flange ring (for 
measuring cell), (4) display, (5) touch panel, (6) 
side cover (one on each side), (7) instrument feet. 
The upper end of the measuring system needs to be 
inserted into the coupling. In this thesis rotational 
experiments with controlled shear rate were 
performed with cone-and-plate measuring system. 
Sample is applied on the plate, then cone is 
lowered down and sample is trimmed to reach the 
correct amount of sample, because too much and 
too little sample will lead to large errors in the 
measurement data. The ideal amount of the 
sample is shown in figure 13 (43). The cone 
rotates while the lower plate is stationary. The 
rheometer is connected to the computer with the 
rheometer software required. The parameter shear 
stress is a preset value and the parameter shear rate 
is a result of the test. Viscosity is calculated using 
the law of viscosity (41).  
Figure 12 – The rheometer, taken from 
Anton Paar 
Figure 13 – Cone-and-plate measuring 
system filled with the correct amount of the 
sample, taken from Anton Paar 
Figure 11 – Viscosity function of a polymer displaying three stages on a double logarithmic 
scale: (1) the first Newtonian range 𝜂0, (2) the shear-thinning range 𝜂 = f (𝛾) and (3) the second 




The overall aim of this thesis was to prepare stable polymer-based NPs for potential use in 
patients with xerostomia.  
The objectives of this thesis were: 1) to produce stable NPs, 2) to investigate the interaction 
between NPs and mucin by rheology in vitro and 3) to adjust the viscosity of the nanoparticle 
dispersions with a neutral polymer. 
The polysaccharides alginate, LM-pectin and chitosan were used in the production of NPs by 
ionic-cross linking since they show mucoadhesive properties and have hydrophilic groups 
which can bind water molecules. After preparation, the NPs were characterized according to 
their size, PDI, ZP and turbidity. The stability of the NPs over time was also examined. Some 
criteria were set and had to be achieved to consider the NPs as appropriate: The size of the NPs 
should be between 100 and 500 nm; the PDI should be below 0,3; the absolute value of ZP 
should be larger than 30 mV and the samples should contain no visible aggregates (turbidity 
close to 0 cm-1).  
The interaction of the NPs with mucin in vitro was investigated by rheology in order to see a 
possible change in viscosity when having interaction between NPs and mucin. The viscosity of 
different samples (polymers, NPs, mucin and combination of mucin and NPs or polymers) was 
measured by rotational experiments with controlled shear rate. Influence of different solvents 
on the viscosity was also investigated.  
In order to modify the viscosity of the nanoparticle formulation to behave similar to human 
saliva, the neutral polymer hydroxethylcellulose (HEC) was added to the nanoparticle 
dispersions. Change in the viscosity and contribution of the NPs were scrutinized. Flowchart of 
the laboratory work can be seen in figure 14 below.  
 
Figure 14 – Flowchart of the laboratory work 
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3 MATERIALS, METHODS AND EXPERIMENTAL DESIGN 
3.1 Materials 
Materials used for the experimental part of the master thesis are listed in table III. 
Table III – Materials used for the master thesis 
Polysaccharide Specific properties Batch Number Producer 
Chitosan chloride 
(Protasan UP Cl 213) 
 
Mw= 307 kDa* 
DDA 83% (Degree of 
deacetylation) 
*Jonassen et al. (24) 




pectin LM-12 CG-Z) 
DE 35% (Degree of 
esterification) 
Mw= 76 kDa* 
*Nguyen et al. (44) 




(Protanal® LF 10/60) 
Mw= 147 kDa* 
G-content = 65 – 75% 
M-content = 25 – 35% 
*Pistone et al. (22) 
S19905 FMC Biopolymer 
a.s (Drammen, 
Norway) 
Cross linker Specific properties Batch Number Producer 
Zinc chloride Anhydrous 
Assay > 98,0% 




pentabasic (TPP)  
Assay > 98,0% 
Mw = 367,86 g/mol 
139428130809009 Sigma-Aldrich® 
(Germany) 
Other chemicals used Specific properties Batch Number Producer 
Mucin from bovine 
submaxillary glands 
(BSM) 
Type I-S SLBL5233V Sigma-Aldrich® 




Mw ≈ 150 000 g/mol SLBR0333V Sigma-Aldrich
® 
(St. Louis, USA) 
Sodium chloride content: min. 99,5% 
Mw = 58,48 g/mol 




content: 99,0 – 102,0% 
Mw = 137,99 g/mol 




content: min. 99,5% 
Mw = 177,99 g/mol 




Mw ≈ 90 000 g/mol 
Type 250 L PHARM  






3.2.1 LM-pectin purification  
LM-pectin was purified by dissolving LM-pectin 1,5% w/w in distilled water and stirred 
overnight at room temperature. The next day approximately 2500 ml of the LM-pectin solution, 
1,5% w/w, was divided into 4 plastic centrifugation bottles and centrifuged for 60 minutes at 
4400 rpm (The Multifuge® 4KR, Heraeus®). After centrifugation the LM-pectin solutions were 
decanted, centrifuged for an additional 60 minutes at the same speed and decanted again. The 
LM-pectin solutions were dialyzed against distilled water using Spectra/Por® 6 dialysis 
membrane with a molecular weight cut-off 8000 Da (Spectrum Laboratories Inc., CA, USA). 
The dialysis membranes were soaked in distilled water before use to remove Na-azide. After 
filling the tubes with 200 ml of the LM-pectin solution, they were placed in 1000 ml cylinder, 
filled up with distilled water and stored in the refrigerator. The water in the cylinders was 
changed twice or once a day for next 7 days. On day 10, 200 ml of LM-pectin solution was 
placed in 1000 ml lyophilization flask and frozen during rotation in a Therminol® D12 bath. It 
was freeze dried for 3 days at the pressure below 1 mbar (Christ Alpha 2-4 freeze drier, Christ, 
Osterode am Harz, Germany). On day 14, purified LM-pectin was removed from lyophilization 
flask with tweezers and stored in the refrigerator. LM-purification steps can be seen in figure 
15. 
          
A    B            C                D    E 
                 
F            G                      H                     I          J 
Figure 15 – LM-pectin purification steps; A) LM-pectin in powder form; B) LM-pectin 
dissolved in distilled water after stirring overnight ; C) centrifugation bottles filled with 
dissolved LM-pectin before centrifugation; D) centrifuge; E) dialysis tube with LM-pectin 
solution in a cylinder filled with distilled water; F) LM-pectin solution in a lyophilization flask; 
G) freezing of the LM-pectin solution in a Therminol® D12 bath; H) freeze drying; I) 3 days 
after lyophilization; J) purified LM-pectin 
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3.2.2 Preparation of polysaccharide-based nanoparticles 
NPs were produced by ionic crosslinking, based on the method that was already established at 
the School of Pharmacy, University of Oslo (24). The method is based on adding a crosslinker 
solution to a polymer solution under magnetic stirring. 
The procedure was the same for all three types of NPs (chitosan, alginate and LM-pectin), only 
the amount of polymer and crosslinker were varying in order to get NPs with different polymer 
concentration and polymer to crosslinker ratios (See chapter 3.3.1 Experimental design, 
Preparation of polysaccharide-based nanoparticles). 
On day one polymer and crosslinker starting solutions in excess volume were prepared in glass 
beakers and stirred at room temperature overnight covered with parafilm. 0,05 M NaCl was 
used as a solvent. Crosslinker starting solution was prepared from the stock solution (5% w/w 
ZnCl2 or TPP in 0,05 M NaCl).  
The next day, 100 mL and 20 mL vials were rinsed with fresh milliQ water and dried bottom 
up on a stand. Peristaltic pump (type 520S, Watson-Marlow, Great Britain) was prepared by 
fitting a silicone hose (inner diameter 1,52 mm) inside. The inner part of the hose was rinsed 
by using at least 30 mL of fresh milliQ water by activating the pump. External edges of the hose 
were rinsed with filtered milliQ water (Millex® GV 0,22 µm). In order to avoid dust, the 
polymer and the crosslinker solutions were filtered using Millex® AA 0,8 µm and Millex® GV 
0,22 µm, respectively. 60 g of filtered polymer solution was weighed in the rinsed 100 mL vial 
and 15 g of filtered crosslinker solution was weighed in the rinsed 20 mL vial. A magnet (2 cm) 
was rinsed with filtered milliQ water (Millex® GV 0,22 µm) and put in the polymer solution 
which was then placed on the magnetic stirrer at level 5.  
One edge of the hose was placed in the crosslinker vial until it reached the bottom of the vial. 
The other edge of the hose was placed in another vial, few centimeters above the polymer 
solution to let the crosslinker solution drop in the middle of the cone formed while stirring. 
Both vials were closed with rubber stoppers with a hole and the hose passed through the holes. 
Additionally, the aluminum foil was used to move the stoppers and the hose more easily.  
The hose was rinsed with the solution that would pass through the hose during the preparation 
of the next sample. This was repeated every time when the crosslinker solution was changed. 
The peristaltic pump was started at 25 rotations per minute (rpm). In order to control that the 
pump was working, the time between the first and the last drop of the crosslinker solution was 
measured with a chronometer. The nanoparticle dispersion was kept stirring for 10 minutes 
from the first drop. The vial containing the nanoparticle dispersion was closed with a rubber 
stopper which was previously rinsed with filtered MilliQ water (Millex® GV 0,22 µm). At the 
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end of the preparation of all the samples, the hose was rinsed again with fresh MilliQ water and 
hung for drying. During the nanoparticle preparation the same size of magnet, vials, speed of 
the peristaltic pump and magnetic stirring were held constant, because it might affect the results 
such as different size of NPs. The samples were kept overnight at room temperature in order to 
complete the formation and were characterized the next day. Three separate batches with the 
same composition were always prepared. During the next the two months the alginate NPs were 
stored at the room temperature whereas the chitosan and the LM-pectin NPs were stored in the 
refrigerator for one month. The scheme of the preparation of polysaccharide-based NPs and the 
photo of the actual preparation can be seen in figure 16 and figure 17.  
 
Figure 16 – The scheme of the preparation of polysaccharide-based NPs 
 
Figure 17 – Photo of the actual preparation of the NPs 
3.2.3 Characterization of the nanoparticles 
3.2.3.1 Size (average hydrodynamic diameter), polydispersity index and zeta potential 
Measurements of the size (average hydrodynamic diameter), PDI and the ZP were performed 
at 25 °C with the Zetasizer Nano - ZS (Malvern Instruments Ltd., Worchestershire, UK). 1 mL 
of each sample was prepared in disposable polystyrene cuvettes and used both for size and ZP 
measurements. Cells were equilibrated for 300 seconds before size measurements and 120 
seconds before ZP measurements. The refractive index and viscosity of pure water at 25 °C 
were used as constant parameters in the calculations. 
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The average hydrodynamic diameter of each batch was calculated from 3 measurements that 
were automatically performed on the Zetasizer Nano ZS. The average hydrodynamic diameter 
values reported were calculated as an arithmetic mean of 3 separate batches with the same 
sample composition.  
A zeta dip cell was used for ZP measurements. In order to ensure validity of measurements, ZP 
standard (-42 mV) was always measured before the real samples. Between each sample the 
electrode was rinsed with distilled and MilliQ water. The average ZP of each batch was 
calculated from 5 measurements that were automatically performed and final average ZP was 
calculated as an arithmetic mean of 3 separate batches of the same sample. 
3.2.3.2 Turbidity  
Transmitted light intensity was measured with UV-VIS spectrophotometer UV-2550, 
Schimadzu Corporation at a wavelength of 550 nm. 3 mL of each sample was prepared in 
disposable polystyrene cuvettes and closed with a fitting stopper. Transmitted light was 
measured once for each batch and average transmittance was calculated as arithmetic mean of 
3 separate batches of the same sample. Turbidity was calculated using the Lambert-Beer's law. 
MilliQ water was used as a blank solution.  
3.2.3.3 Stability over time 
For the most stable nanoparticle dispersions long term stability was observed. Size, PDI and 
zeta potential were measured over period of four or eight weeks.  
3.2.4 Viscosity measurements 
Viscosity experiments were conducted at 37 °C in a Paar-Physica MCR 301 rheometer using a 
cone-and-plate geometry with a cone angle of 1° and diameter of 74,976 mm. The temperature 
unit (a Peltier plate), a part of the rheometer, gave good temperature control over an extended 
time.  
In order to ensure the consistent quality of the measurements air check was required. If values 
were outside the limits, motor adjustments were performed. Before measuring the samples, the 
viscosity of distilled water was measured and compared to values found in the viscosity table – 
measurement data. 
Before sample application the cone and plate were first sprinkled with ethanol and wiped with 
laboratory tissues. Then the surface was wiped with acetone dropped on linse paper in order to 
avoid dust and small particles. Approximately 4-5 mL of a sample was added with a spoon in 
the middle of the plate. Pipettes or syringes are not suitable for sample application because high 
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shear load can result in reduced measurement values. Lift position was 10 mm and measuring 
position was 0,151 mm. When the sample was applied, the cone was lowered to trimming 
position which was 0,161 mm. Excess amount of the sample was removed with a pipette and 
then the measuring position was reached. Calibration time was 5 minutes. Initial shear rate was 
0,1 1/s or 10 1/s and final 100 1/s. Measuring point duration was varying from initial 15 s to 
final 5 s. Interval duration was 110 seconds and there were 11 measuring points. 
3.2.5 Nanoparticle up-concentration 
The nanoparticle up-concentration was based on dialysis against a dextran solution in 0,05 M 
NaCl. The solvent tends to move from the nanoparticle dispersion to the dextran solution. NPs 
do not diffuse through the semi-permeable membrane and the concentration of NPs becomes 
higher.  
Dialysis tube (Spectra Por® Dialysis Membrane, MWCO 8000 Da, diameter 32 mm) was 
soaked in distilled water for 45 minutes in order to remove Na-azide, filled with nanoparticle 
dispersion and tightly closed with closures on both sides. Dextran was dissolved in 0,05 M 
NaCl to get the desired concentration of 200 g/L. The filled dialysis membrane was placed in 
the beaker and dextran solution was poured into the beaker so that whole membrane was 
covered and kept at room temperature for defined time. The concentration of nanoparticle 
dispersion was calculated from weight of nanoparticle dispersion in dialysis tube before and 
after up-concentration. 
Volume of NPs before and after up-concentration, volume of dextran solution and time needed 
for dialysis are stated in table IV below. Size, PDI and zeta potential of nanoparticle dispersions 
were always measured before and after up-concentration.  
Table IV – Up-concentration parameters (Volume of NPs –before, concentration of NPs – 
before, volume of dextran solution, time, volume of NPs – after and concentration of NPs – 
after)  
Volume of 
NPs – before 
(mL) 
Concentration 








NPs – after 
(mL) 
Concentration 
of NPs – after 
(%, w/w) 
30 0,05 50 10 15 0,10 
20 0,07 40 12 6,6 0,21 
3.3 Experimental design 
This chapter is divided into two parts – 1) Preparation of polysaccharide-based NPs and 2) 
Viscosity measurements.  
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3.3.1 Preparation of polysaccharide-based nanoparticles 
Exact polymer concentration, crosslinker to polymer ratio (w:w) and solvent used in the 
preparation of NPs can be found in this chapter. Procedure is described in the chapter 3.2.2 
Methods, Preparation of polysaccharide-based nanoparticles. Briefly, 15 g of crosslinker (ZnCl2 
or TPP) was added dropwise to 60 g of polymer (alginate, LM-pectin or chitosan) solution. All 
polymer concentrations in the tables are concentrations in the final solutions. Some of the 
nanoparticle batches were used in the following experiments (stability studies or investigation 
of the interaction between mucin and NPs) and are listed below each table (a,b). All 
formulations were prepared in triplicate.  
Alginate nanoparticles (ionic cross-linking of alginate with ZnCl2) 
Alginate-ZnCl2 NPs were prepared. Two different polymer concentration and crosslinker to 
polymer ratios were used as can be seen in table V.  
Table V – Polymer concentration and crosslinker to polymer ratio used for preparation of 
alginate NPs 
Polymer concentration (%, w/w) Crosslinker to polymer ratio (w:w) Solvent 
0,05 35:65a 0,05 M NaCl 
0,07 30:70b 0,05 M NaCl 
a Crosslinker to polymer ratio tested in the stability studies 
b Combination used for investigating interaction between mucin and NPs 
LM-pectin nanoparticles (ionic crosslinking of LM-pectin with ZnCl2) 
LM-pectin-ZnCl2 NPs were prepared. Two different polymer concentrations were tested with 
different crosslinker to polymer ratios as can be seen in table VI. The most stable combinations 
were chosen for further experiments. 





polymer ratio (w:w) 
Solvent 
0,05 15:85 0,05 M NaCl 
0,05 20:80 a 0,05 M NaCl 
0,05 25:75 0,05 M NaCl 
0,07 10:90 0,05 M NaCl 
0,07 15:85 b 0,05 M NaCl 
0,07 20:80 0,05 M NaCl 
0,07 25:75 0,05 M NaCl 
a Crosslinker to polymer ratio tested in the stability studies 
b Combination used for investigating interaction between mucin and NPs 
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Chitosan nanoparticles (ionic cross-linking of chitosan with TPP) 
Chitosan-TPP NPs were prepared. Two different polymer concentration were tested with 
different crosslinker to polymer ratios as can be seen in table VII. The most stable combinations 
were chosen for further experiments. 
Table VII – Polymer concentration and crosslinker to polymer ratio used for preparation of 
chitosan NPs 
Polymer concentration (%, w/w) Crosslinker to polymer ratio (w:w) Solvent 
0,05 15:85 a 0,05 M NaCl 
0,05 20:80 a 0,05 M NaCl 
0,05 25:75 0,05 M NaCl 
0,07 15:85 b 0,05 M NaCl 
a Crosslinker to polymer ratio tested in the stability studies 
b Combination used for investigating interaction between mucin and NPs 
3.3.2 Viscosity measurements 
Adjustment of the method 
In order to find the most appropriate parameters (concentration of polymer or NPs, solvent and 
shear rate) for viscosity measurements, different concentrations of solutions of alginate and 
mucin were tested on the rheometer. 
Alginate (variable parameters: concentration, solvent, shear rate) 
First of all, the viscosity of alginate solutions at different concentrations was measured. The 
solvent was 5 mM phosphate buffer (pH 6,8) or 0,05 M NaCl. Shear rate was varying from 0,1 
or 10 to 100 1/s. Alginate concentration (%, w/w), solvent used and shear rate (1/s) can be seen 
in table VIII.  
Table VIII – Alginate concentration, solvent and shear rate used in the viscosity measurements 
Alginate concentration (%, w/w) Solvent Shear rate (1/s) 
0,05 5 mM phosphate buffer 10 – 100 
0,10 5 mM phosphate buffer 10 – 100 
0,15 5 mM phosphate buffer 10 – 100 
0,50 5 mM phosphate buffer 0,1 – 100 
1,00 5 mM phosphate buffer 0,1 – 100 
1,50 5 mM phosphate buffer 0,1 – 100 
0,50 0,05 M NaCl 10 - 100 
Mucin (variable parameters: concentration, solvent) 
The viscosity of the mucin solution was measured at different mucin concentrations from 0,05 
to 0,50% w/w in three different solvents – 5 mM phosphate buffer, 0,05 M NaCl or mixture of 
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both 5 mM phosphate buffer and 0,05 M NaCl. The initial shear rate was 10 and final 100 1/s. 
Mucin concentration (%, w/w), solvent and shear rate can be seen in table IX.  
Table IX – Mucin concentration, solvent and shear rate used in the viscosity measurements 
Mucin concentration (%, w/w) Solvent Shear 
rate (1/s) 
0,05 5 mM phosphate buffer 10 – 100 
0,10 5 mM phosphate buffer 10 – 100 
0,50 5 mM phosphate buffer 10 – 100 
0,05 0,05 M NaCl 10 – 100 
0,10 0,05 M NaCl 10 – 100 
0,50 0,05 M NaCl 10 – 100 
0,25 5 mM phosphate buffer : 0,05 M NaCl = 1:1 10 – 100 
0,50 5 mM phosphate buffer : 0,05 M NaCl = 1:1 10 – 100 
Interaction of the different polymers with mucin 
Viscosity of three different samples was measured – mucin solution, polymer solution and 
mixture of polymer and mucin. Based on the results from experiments above (Adjustment of 
the method), the final polymer and mucin concentration in the samples were defined. Polymers 
and mucin were dissolved in the same solvents listed in table X. 
The mucin solution was added dropwise while stirring to each polymer solution (alginate, LM-
pectin and chitosan), and the viscosity was measured at shear rates from 10 to 100 1/s. All 
concentrations listed in table X are concentrations in the final solutions. 
Table X – Final polymer (alginate, LM-pectin or chitosan) concentration in the sample, final 
mucin concentration in the sample, solvent and shear rate 
Final polymer 
concentration in the 
sample (%, w/w) 
Final mucin 
concentration in the 





0,00 0,25 5 mM phosphate buffer : 0,05 
M NaCl = 1:1 
10 – 100 
0,50 0,00 0,05 M NaCl 10 – 100 
0,50 0,25 5 mM phosphate buffer : 0,05 
M NaCl = 1:1 
10 – 100 
Interaction of the nanoparticles with the mucin  
Since the concentration of the nanoparticle dispersions was very low compared to the mucin 
concentration and even lower after diluting when the mucin solution was added, NPs were first 
up-concentrated. After up-concentration the mucin solution was added dropwise while stirring 
to the up-concentrated NPs. All the concentrations of different NPs and mucin solution are 
listed in table XI.  
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The viscosity of two different samples was measured – NPs before up-concentration and 
mixture of up-concentrated NPs and mucin. The results of the viscosity measurements were 
also compared to previous viscosity measurement of mucin solution.  
Table XI – NPs concentration before and after up-concentration, final NPs concentration in 
the sample, final mucin concentration in the sample and shear rate 
Adjusting the viscosity of the nanoparticle dispersion 
Viscosity of three different concentrations of HEC solutions in 0,05 M NaCl was measured. 
Final HEC concentrations are defined in table XII below. 
Nanoparticle dispersions of concentration 0,05% w/w were up-concentrated to 0,10% w/w. 
HEC solution was added dropwise to up-concentrated nanoparticle dispersion while stirring on 
a magnetic stirrer so that concentration of NPs in the final sample was 0,05% w/w. Viscosity 



























































Table XII – Final HEC concentration in the sample, final NPs concentration in the sample, 
solvent and shear rate 
Final HEC concentration 
in the sample (%, w/w) 
Final NPs 
concentration in the 





0,5 / 0,05 M NaCl 0,1 – 100 
1,0 / 0,05 M NaCl 0,1 – 100 
1,5 / 0,05 M NaCl 0,1 – 100 
Chitosan NPs 
0,5 0,05 0,05 M NaCl 0,1 – 100 
1,0 0,05 0,05 M NaCl 0,1 – 100 
1,5 0,05 0,05 M NaCl 0,1 – 100 
/ 0,05 0,05 M NaCl 0,1 – 100 
Alginate NPs 
0,5 0,05 0,05 M NaCl 0,1 – 100 
1,0 0,05 0,05 M NaCl 0,1 – 100 
1,5 0,05 0,05 M NaCl 0,1 – 100 
/ 0,05 0,05 M NaCl 0,1 – 100 
LM-pectin NPs 
0,5 0,05 0,05 M NaCl 0,1 – 100 
1,0 0,05 0,05 M NaCl 0,1 – 100 
1,5 0,05 0,05 M NaCl 0,1 – 100 
/ 0,05 0,05 M NaCl 0,1 – 100 
 
Additionally, the viscosity of Biotène®, a product available on the Norwegian market, was 




4.1 Preparation of polysaccharide-based nanoparticles  
4.1.1 Alginate nanoparticles - ionic cross-linking of alginate with ZnCl2 
Alginate NPs (alginate = 0,05% w/w, ZnCl2 : alginate ratio = 35:65) were successfully prepared. 
The size measured one day after preparation was 200 nm, PDI was 0,27 and ZP was -31 mV. 
No large particles or aggregation were observed with the naked eye and the turbidity was 0,01 
cm-1. The NPs were stored at room temperature for the next two months and their size, PDI and 
ZP were measured after seven days, one month and two months. The average hydrodynamic 
diameter increased only 30 nm and the PDI remained the same after two months (figure 18). 
The ZP after two months was almost the same as the first day after preparation (figure 19). 
Since it turned out that the concentration for further investigations of the interaction of the NPs 
with mucin needs to be as high as possible, alginate NPs with higher alginate concentration 
were also prepared (alginate = 0,07% w/w, ZnCl2 : alginate ratio = 30:70). Their average 
hydrodynamic diameter was 268 nm, PDI was 0,30 and ZP was -30 mV. Those NPs were used 
in the further experiments. 
 
Figure 19 – The zeta potential (mV) of alginate-ZnCl2 NPs (alginate = 0,05% w/w, ZnCl2 : 
































































Figure 18 – The hydrodynamic diameter (nm) and PDI of alginate NPs (alginate = 0,05% w/w, 
ZnCl2 : alginate ratio = 35:65) as a function of time 
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4.1.2 LM-pectin nanoparticles - ionic crosslinking of LM-pectin with ZnCl2 
Characteristics of LM-pectin-ZnCl2 nanoparticles (LM-pectin = 0,05% w/w, ZnCl2 : LM-pectin 
ratio = 15:85, 20:80 or 25:75, solvent = 0,05 M NaCl) measured after one day 
In contrast to alginate NPs, several different crosslinker to polymer ratios were tested in order 
to find an optimal formulation of LM-pectin NPs. First, the concentration of LM-pectin was 
0,05% w/w and three different ZnCl2 to LM-pectin ratios (15:85, 20:80 and 25:75) were 
investigated. As can be seen in figure 20, the size of the NPs is increasing with increasing ZnCl2 
concentration. ZP was similar in all three formulations, varying from -16 mV to -18 mV (figure 
21).  
In the sample with ZnCl2 to LM-pectin ratio 25:75 there was macroscopic aggregation after one 
day and the sample was cloudy correlated to the increased size of the particles (more than 3000 
nm) and a high turbidity (0,39 cm-1) (figure 22). Also, the error bars for both, size and PDI, 
were large. The lowest PDI (0,36) was observed in the sample with ZnCl2 to LM-pectin ratio 
20:80. The most promising formulation was concluded to be the sample with ZnCl2 to LM-








































ZnCl2 : LM-pectin ratio
Figure 20 – The hydrodynamic diameter (nm) and PDI of LM-pectin- ZnCl2 NPs as a function 
of ZnCl2 to LM-pectin ratio measured after one day. *Macroscopic aggregation after one day 
Figure 21 – The zeta potential (mV) of LM-
pectin- ZnCl2 NPs as a function of the ZnCl2 to 
LM-pectin ratio measured after one day 
Figure 22 – The turbidity of LM-pectin- 
ZnCl2 NPs as a function of the ZnCl2 to LM-














































Characteristics of LM-pectin-ZnCl2 nanoparticles (LM-pectin = 0,05% w/w, ZnCl2 : LM-
pectin ratio = 20:80, solvent = 0,05 M NaCl) measured over time 
The hydrodynamic diameter of the LM-pectin NPs increased from 335 nm to 960 nm and error 
bars became larger after one month. Even after just one week the size increased from 335 nm 
to 488 nm. The PDI increased from starting 0,36 to 0,49 after one month (figure 23). The ZP 
did only change slightly after one month (figure 24), it was between -17mV to -15mV during 
the whole time-frame. 
 
Figure 23 – The hydrodynamic diameter (nm) and PDI of LM-pectin-ZnCl2 NPs (LM-pectin = 
0,05% w/w, ZnCl2 : LM-pectin ratio = 20:80, solvent = 0,05 M NaCl) as a function of time 
 
Figure 24 – The zeta potential (mV) of LM-pectin-ZnCl2 NPs (LM-pectin = 0,05% w/w, ZnCl2 
: LM-pectin ratio = 20:80, solvent = 0,05 M NaCl) as a function of time 
Characteristics of LM-pectin-ZnCl2 nanoparticles (LM-pectin = 0,07% w/w, ZnCl2 : LM-pectin 
ratio = 10:90, 15:85, 20:80 or 25:75, solvent = 0,05 M NaCl) measured after one day 
Four different ZnCl2 to LM-pectin ratios were attempted prepared – 10:90, 15:85, 20:80 and 
25:75. The size and PDI of the measured samples can be seen in figure 25. In the sample with 
ZnCl2 to LM-pectin ratio 25:75 there was macroscopic aggregation which could be observed 
with the naked eye (figure 26) and was correlated to high turbidity (0,88 cm-1). Results for this 
sample were not included in the figures. The smallest particles (326 nm) were formed in the 
sample with ZnCl2 to LM-pectin ratio 15:85. The PDI was higher than 0,4 in all the samples. 
The lowest PDI (0,47) was observed in the sample with the ZnCl2 to LM-pectin ratio 20:80, but 





































































-17 mV in the samples with ZnCl2 to LM-pectin ratio 10:90 and 15:85 and -13 mV in the sample 
with ZnCl2 to LM-pectin ratio 20:80 (figure 27). The sample with ZnCl2 to LM-pectin ratio 15: 
85 was chosen for further investigations of the interaction between NPs and mucin due to the 
smallest size of the NPs and absence of the macroscopic aggregation.  
 
  
Figure 26 – The actual photo of four different samples with ZnCl2 to LM-pectin ratios 10:90, 

















































































ZnCl2 : LM-pectin ratio
Figure 28 – The turbidity of LM-pectin-
ZnCl2 NPs as a function of the ZnCl2 to 
LM-pectin ratio measured after one day 
Figure 27 – The zeta potential (mV) of LM-
pectin- ZnCl2 NPs as a function of the ZnCl2 to 
LM-pectin ratio measured after one day  
Figure 25 –The hydrodynamic diameter (nm) and PDI of LM-pectin-ZnCl2 NPs as a 
function of ZnCl2 to LM-pectin ratio measured after one day 
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4.1.3 Chitosan nanoparticles - ionic cross-linking of chitosan with TPP 
Characteristics of chitosan-TPP nanoparticles as a function of the TPP to chitosan ratio 
measured one day after preparation 
First, chitosan NPs with chitosan concentration 0,05% w/w and three different TPP to chitosan 
ratios (15:85, 20:80 and 25:75) were attempted prepared. Those NPs were the smallest among 
all polysaccharide-based NPs prepared in this thesis. The smallest NPs (110 nm) were formed 
in the sample with TPP to chitosan ratio 20:80. The size of the NPs in the samples with TPP to 
chitosan ratio 15:85 and 25:75 was 120 nm and 134 nm, respectively (figure 29).  
The PDI was varying from 0,12 to 0,16 (figure 29). The ZP was decreasing from 20 mV to 9 
mV with increasing concentration of TPP (figure 30). All the samples had a turbidity of almost 
0 cm-1 (figure 31) and there was no macroscopic aggregation.  
Two samples with TPP to chitosan ratio 15:85 and 20:80 were stored for one month and used 
for stability studies. Furthermore, chitosan NPs with chitosan concentration 0,07% w/w and 
TPP to chitosan ratio 15:85 were also prepared and later used for investigation of the interaction 
Figure 30 – The zeta potential (mV) of 
chitosan-TPP NPs as a function of the TPP 
to chitosan ratio measured after one day 
Figure 31 – The turbidity of chitosan-TPP 
NPs as a function of the TPP to chitosan ratio 


















































































TPP : chitosan ratio
Figure 29 – The hydrodynamic diameter (nm) and PDI of chitosan-TPP NPs as a function 




of the chitosan NPs with mucin. Their hydrodynamic diameter was 169 nm, PDI was 0,18 and 
ZP was 25,4 mV.  
Characteristics of chitosan-TPP nanoparticles (chitosan = 0,05% w/w, TPP-chitosan ratio = 
15:85 or 20:80, solvent = 0,05 M NaCl) measured over time 
The hydrodynamic diameter increased only for 12 nm and 28 nm during one month in the 
samples with the TPP to chitosan ratio 15:85 and 20:80, respectively (figure 32). PDI did not 
change much during the time the NPs were stored. The PDI of the sample with TPP to chitosan 
ratio 20:80 was slightly smaller than the ratio of 15:85 (figure 32). As can be seen in figure 33, 
the ZP was positive and stable most of the time during one month, with a sudden change after 
one week which might be due to experimental error. At the end, the ZP was 22 mV for the 
sample with TPP to chitosan ratio 15:85 and 13 mV for the sample with TPP to chitosan ratio 
20:80. 
Figure 33 – The zeta potential (mV) of chitosan-TPP NPs (chitosan = 0,05% w/w, TPP : 
chitosan ratio = 20:80, solvent = 0,05 M NaCl and chitosan = 0,05% w/w, TPP : chitosan ratio 





























20 : 80 15 : 85
Figure 32 – The hydrodynamic diameter (nm) and PDI of chitosan-TPP NPs (chitosan = 0,05% 
w/w, TPP : chitosan ratio = 20:80, solvent = 0,05 M NaCl and chitosan = 0,05% w/w, TPP : 
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4.2 Viscosity measurements 
4.2.1 Adjustment of the method 
Alginate (variable parameters: concentration, solvent, shear rate) 
In figure 34 three viscosity curves of the samples with different alginate concentrations (0,5% 
w/w, 1% w/w and 1,5% w/w) in 5 mM phosphate buffer solutions measured at shear rate from 
0,1 to 100 1/s can be seen. The viscosity was higher when the alginate concentration was higher 
and vice versa for lower concentrations of alginate. Also, for the lowest alginate concentration 
(0,5% w/w), the error bars were larger than for the highest alginate concentration (1,5% w/w), 
where the error bars were smaller. All three curves were decreasing and reached the infinite-
shear viscosity 𝜂∞ (flat part of the curves) at the shear rate from 10,0 to 100,0 1/s. Error bars 
were smaller in this area. The viscosity at shear rate 100 1/s was 0,0057 Pas for the sample with 
alginate concentration 0,5% w/w, 0,0164 Pas for the sample with alginate concentration 1,0% 
w/w and 0,0439 Pas for the sample with alginate concentration 1,5% w/w.  
Figure 35 shows the viscosity curves of six different concentrations of alginate (0,05% w/w, 
0,1% w/w, 0,15% w/w, 0,5% w/w, 1% w/w and 1,5% w/w) in 5 mM phosphate buffer solutions 
measured at shear rate from 10 to 100 1/s. All six curves were flat and presented the infinite-
shear viscosity 𝜂∞. The viscosities at shear rate 100 1/s were 0,0010 Pas, 0,0014 Pas, 0,0018 
Pas, 0,0057 Pas, 0,0116 Pas and 0,0438 Pas for samples with the alginate concentration 0,05% 
w/w, 0,1% w/w, 0,15% w/w, 0,5% w/w, 1% w/w and 1,5% w/w, respectively.  
The influence of the solvent was also investigated. The viscosity of the alginate solution with 
concentration 0,5% w/w in two different solvents (0,05 M NaCl and 5 mM phosphate buffer) 
was measured at shear rate from 10 to 100 1/s. The viscosity was lower in the sample containing 
















% w/w of alginate in 5 mM phosphate buffer
0,5 1 1,5
Figure 34 – Viscosity curves of the samples with different alginate concentrations in 5 mM 
phosphate buffer solutions measured at shear rate from 0,1 to 100 1/s 
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mM phosphate buffer where viscosity at the same shear rate was 0,0057 Pas (figure 36). 
Alginate concentration 0,5% w/w in 0,05 M NaCl was chosen for the further experiments.  
Mucin (variable parameters: concentration, solvent) 
The viscosity curves of the samples with different mucin concentrations in different solvents 
measured at shear rate from 10 to 100 1/s are presented in figure 37. Similar to the samples in 
the previous chapter (Alginate (variable parameters: concentration, solvent, shear rate)) higher 
concentration of mucin led to higher viscosity. Sample with mucin concentration 0,5% w/w had 
the highest viscosity and sample with mucin concentration 0,05% w/w had the lowest viscosity.  
A low mucin concentration (0,05% w/w or 0,1% w/w) correlated to larger error bars. The 
influence of the solvent was investigated as well. Samples with the same mucin concentration 
Figure 35 – Viscosity curves for different concentration of alginate in 5 mM phosphate buffer 
solutions measured at shear rate from 10 to 100 1/s  
Figure 36 – Viscosity curves for 0,5% w/w alginate in 5 mM phosphate buffer and 0,05 M NaCl 
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were measured in two different solvents, 5 mM phosphate buffer and 0,05 M NaCl. The 
viscosity was always lower when mucin was dissolved in 0,05 M NaCl compared to 5 mM 
phosphate buffer. Sample with the mucin concentration 0,5% w/w was also prepared in 
combined solvent, 5 mM phosphate buffer : 0,05 M NaCl = 1:1. Viscosity at shear rate 100 1/s 
of this sample was 0,0014 Pas whereas viscosity of the same mucin concentration (0,5% w/w) 
in 0,05 M NaCl was 0,0013 Pas. Finally, a mucin concentration of 0,25% w/w in 5 mM 
phosphate buffer : 0,05 M NaCl = 1:1 was chosen for further experiments.  
4.2.2 Interaction studies of the different polymers and mucin and the rheological 
synergism 
Interaction studies of the alginate solution and mucin 
After addition of mucin to the alginate solution, there was no change in the sample observed 
with the naked eye. Three different viscosity curves measured at shear rate 10 to 100 1/s can be 
found in figure 38. The curve for the sample of alginate and mucin (0,5% w/w alginate and 
0,25% w/w mucin in combined solvent) was not totally flat, but was decreasing at low shear 
rates. The viscosity at a shear rate of 100 1/s was 0,0051 Pas. The curve for the sample of 
alginate (0,5% w/w alginate in 0,05 M NaCl) was slightly decreasing and the viscosity at a 
Figure 37 – Viscosity curves of the samples with different mucin concentrations in different 
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shear rate of 100 1/s was 0,0039 Pas. The curve for the sample of mucin (0,25% w/w mucin in 
5 mM phosphate buffer) was flat and the viscosity was 0,0010 Pas at the shear rates from 10 
1/s to 100 1/s.  
 
Figure 38 – Viscosity curves of three different samples – 0,25% w/w mucin in 5 mM phosphate 
buffer : 0,05 M NaCl = 1:1, 0,5% w/w alginate in 0,05 M NaCl and 0,5% w/w alginate and 
0,25% w/w mucin in 5 mM phosphate buffer : 0,05 M NaCl = 1:1 
Interaction studies of the LM-pectin solution and mucin 
Similar results as for alginate were obtained for the mixture of LM-pectin and mucin. There 
was no visible change in the sample when mucin was added to LM-pectin. However, all the 
viscosity curves were flat. The highest viscosity was obtained for the mixture of LM-pectin and 
mucin (0,5% w/w LM-pectin and 0,25% w/w mucin in 5 mM phosphate buffer : 0,05 M NaCl 
= 1:1), see figure 39. The viscosity at a shear rate of 100 1/s was 0,0036 Pas. The viscosity of 
the sample of LM-pectin (0,5% w/w LM-pectin in 0,05 M NaCl) at a shear rate of 100 1/s was 
0,0029 Pas and the viscosity of the sample of mucin (0,25% w/w mucin in 5 mM phosphate 
buffer) was 0,0010 Pas at the shear rates from 10 1/s to 100 1/s.  
 
Figure 39 – Viscosity curves of three different samples – 0,25% w/w mucin in 5 mM phosphate 
buffer : 0,05 M NaCl = 1:1, 0,5% w/w LM-pectin in 0,05 M NaCl and 0,5% w/w LM-pectin and 
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Interaction studies of the chitosan solution and mucin 
After the addition of mucin to the transparent chitosan solution, it became cloudy (figure 40). 
In figure 41 three viscosity curves can be seen. The sample of chitosan (0,5% w/w chitosan in 
0,05 M NaCl) had the highest viscosity. At the shear rate of 100 1/s it was 0,0063 Pas. The 
sample of the mixture of chitosan and mucin (0,5% w/w chitosan and 0,25% w/w mucin in 5 
mM phosphate buffer : 0,05 M NaCl = 1:1) had a viscosity of 0,0046 Pas at the shear rate of 
100 1/s. The sample of mucin (0,25% w/w mucin in 5 mM phosphate buffer : 0,05 M NaCl = 
1:1) had the lowest viscosity, 0,0010 Pas at a shear rate of 100 1/s.  
 
Figure 41 – Viscosity curves of three different samples – 0,25% w/w mucin in 5 mM phosphate 
buffer : 0,05 M NaCl = 1:1, 0,5% w/w chitosan in 0,05 M NaCl and 0,5% w/w chitosan and 
0,25% w/w mucin in 5 mM phosphate buffer : 0,05 M NaCl = 1:1 
The rheological synergism 
The rheological synergism was calculated for all three polymers (alginate, LM-pectin and 
chitosan) using an equation 4 already described in chapter 1.7 (Rheological tests to assess 
mucoadhesive properties). Results from the figure 38, figure 39 and figure 41 were used to 
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NaCl = 1:1
Figure 40 – The sample containing 0,5% w/w chitosan and 0,25% w/w mucin 
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rheological synergism showing the possible interaction between the polymer and mucin. For 
example, the summed viscosity values for the sample of chitosan (0,5% w/w chitosan in 0,05 
M NaCl) and the viscosity values for the sample of mucin (0,25% w/w mucin in 5 mM 
phosphate buffer : 0,05 M NaCl = 1:1) were subtracted from the viscosity values for the sample 
of chitosan and mucin (0,5% w/w chitosan and 0,25% w/w mucin in 5 mM phosphate buffer : 
0,05 M NaCl = 1:1). The same calculation was done for the alginate and LM-pectin. The 
calculated rheological synergism curves are shown in figure 42. The rheological synergism 
values at a shear rate of 100 1/s were 0,0001 Pas for alginate and mucin, -0,0003 for LM-pectin 
and mucin and -0,0028 Pas for chitosan and mucin. Therefore, the rheological synergism 
obtained was positive for alginate and mucin and negative for LM-pectin and mucin, but both 
values were close to the value of 0 Pas. The rheological synergism for chitosan and mucin was 
evidently negative.  
 
Figure 42 – The rheological synergism curves for alginate and mucin, LM-pectin and mucin 
and chitosan and mucin 
4.2.3 Interaction studies of up-concentrated NPs and mucin 
In order to investigate the interaction of the NPs with mucin by rheology, the NPs were first 
up-concentrated. Results of the up-concentration are included in this chapter together with 
rheology results.  
Up-concentrated chitosan NPs and mucin 
First, 0,05% w/w chitosan NPs Sample 1 with TPP to chitosan ratio 15:85 in 0,05 M NaCl were 
prepared and up-concentrated to 0,10% w/w. Average hydrodynamic diameter, PDI and ZP of 
NPs before and after up-concentration are shown in table XIII. The average size increased for 
approximately 15 nm after up-concentration and PDI increased from 0,16 to 0,25. The ZP 
increased from initial 24 mV to 31 mV. Those parameters were also measured after mixing the 







































and PDI was 0,48. The ZP significantly decreased from 31 mV to -14 mV. Hydrodynamic 
diameter, PDI and ZP of the mucin in 5mM phosphate buffer were measured too. The estimated 
size of mucin itself was 770 nm, the PDI was high (0,75) and ZP was negative (-14 mV). In 
figure 43 three solutions can be seen: mucin in 5 mM phosphate buffer, up-concentrated 
chitosan NPs Sample 1 mixed with mucin and chitosan NPs Sample 1. The sample containing 
up-concentrated NPs Sample 1 and mucin was opaque. The viscosity curve of up-concentrated 
NPs Sample 1 (final concentration 0,05% w/w) mixed with mucin (final concentration 0,25% 
w/w) is presented in figure 46. 
Table XIII – Size, PDI and ZP of seven different samples - chitosan NPs Sample 1 and 2 before 
up-concentration, chitosan NPs Sample 1 and 2 after up-concentration, up-concentrated 
chitosan NPs Sample 1 (final concentration 0,05% w/w) mixed with mucin (final concentration 
0,25% w/w), up-concentrated chitosan NPs Sample 2 (final concentration 0,17% w/w) mixed 
with mucin (final concentration 0,25% w/w) and only mucin (0,25% w/w) 
 
Average hydrodynamic 
diameter (nm) PDI 
ZP 
(mV) 
Chitosan NPs Sample 1 before up-concentration 
(0,05% w/w)  129 0,16 24 
Chitosan NPs Sample 1 after up-concentration 
(0,10% w/w) 155 0,25 31 
Up-concentrated chitosan NPs Sample 1 (0,05% 
w/w*) + mucin (0,25% w/w*) 881 0,48 -14 
Chitosan NPs Sample 2 before up-concentration 
(0,05% w/w) 138 0,16 23 
Chitosan NPs Sample 2 after up-concentration 
(0,17% w/w)  182 0,26 10 
Up-concentrated chitosan NPs Sample 2 
(0,085% w/w*) + mucin (0,25% w/w*)  1391 0,53 -13 
Only mucin (0,25% w/w) 770** 0,75 -14 
*final concentrations **Estimated size 
Figure 43 – Mucin in 5 mM phosphate buffer, up-concentrated chitosan NPs Sample 1 (final 
concentration 0,05% w/w) mixed with mucin and chitosan NPs Sample 1 (from left to right) 
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Then 0,05% w/w chitosan NPs Sample 2 (TPP to chitosan ratio 15:85, solvent was 0,05 M 
NaCl) were up-concentrated to 0,17% w/w. Size, PDI and ZP of the chitosan NPs Sample 2 
before up-concentration, chitosan NPs Sample 2 after up-concentration and up-concentrated 
NPs Sample 2 (final concentration 0,085% w/w) mixed with mucin (final concentration 0,25% 
w/w) are given in table XIII. The size of chitosan NPs increased for 44 nm, the PDI increased 
from 0,16 to 0,26 and the ZP decreased from 23 mV to 10 mV after up-concentration. After 
mucin was added dropwise to the up-concentrated chitosan NPs Sample 2, the solution was not 
transparent anymore and became slightly yellow as can be seen in figure 44. Furthermore, there 
was a sediment in the bottom of the vial. The size of the measured particles in the solution 
increased to 1391 nm, PDI was 0,53 and ZP -13 mV. The viscosity curve of up-concentrated 
NPs Sample 2 (final concentration 0,085% w/w) mixed with mucin (final concentration 0,25% 
w/w) can be found in figure 46. 
 
Figure 44 – Up-concentrated chitosan NPs Sample 2 (final concentration 0,085% w/w) mixed 
with mucin 
In order to get higher concentration of the NPs in the sample with mucin, 0,07% w/w chitosan 
NPs Sample 3 with TPP to chitosan ratio 15:85 were prepared in 0,05 M NaCl and up-
concentrated to 0,21% w/w. Size, PDI and ZP of the chitosan NPs Sample 3 before up-
concentration, chitosan NPs Sample 3 after up-concentration and up-concentrated NPs Sample 
3 (final concentration 0,105% w/w) mixed with mucin (final concentration 0,25% w/w) are 
given in table XIV. After mucin was added to chitosan NPs, aggregation occurred and the 
aggregates sank to the bottom of the vial (See figure 45). The viscosity curve of up-concentrated 




NPs Sample 3 (final concentration 0,105% w/w) mixed with mucin (final concentration 0,25% 
w/w) is presented in figure 46. 
Table XIV – Size, PDI and ZP of three different samples - chitosan NPs Sample 3 before up-
concentration, chitosan NPs Sample 3 after up-concentration and up-concentrated chitosan 




diameter (nm) PDI ZP (mV) 
Chitosan NPs Sample 3 before up-concentration 
(0,07% w/w) 169 0,18 25 
Chitosan NPs Sample 3 after up-concentration 
(0,21% w/w) 217 0,27 11 
Up-concentrated chitosan NPs Sample 3 
(0,105% w/w*) + mucin (0,25% w/w*)  5024 1 -12 
*final concentrations in the sample 
 
Figure 46 – Viscosity curves of 0,05% w/w chitosan NPs, 0,07% w/w chitosan NPs, up-
concentrated chitosan NPs Sample 1 (0,05% w/w) + mucin (0,25% w/w), up-concentrated 
chitosan NPs Sample 2 (0,085% w/w) + mucin (0,25% w/w), up-concentrated chitosan NPs 
Sample 3 (0,105% w/w) + mucin (0,25% w/w), and 0,25% w/w mucin in 5 mM phosphate buffer 
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There are six different viscosity curves in figure 46. The viscosity curve for the sample of 0,07% 
w/w chitosan NPs and the viscosity curve for the sample of 0,05% w/w chitosan NPs were both 
slightly decreasing. The viscosity at a shear rate of 100 1/s was 0,00077 Pas for the sample of 
0,07% w/w chitosan NPs and 0,0008 Pas for the sample of 0,05% w/w chitosan NPs. All three 
viscosity curves, up-concentrated NPs Sample 2 (0,085% w/w) + mucin (0,25% w/w), up-
concentrated NPs Sample 1 (0,05% w/w) + mucin (0,25% w/w) and 0,25% w/w mucin in 5 
mM phosphate buffer : 0,05M NaCl = 1:1, were similar: The viscosities at a shear rate of 100 
1/s were 0,0010 Pas and the viscosity curves were flat for those three samples. The viscosity 
curve of up-concentrated NPs Sample 3 (0,105% w/w) + mucin (0,25% w/w) was decreasing 
from the initial viscosity 0,0015 Pas at a shear rate of 10 1/s to final 0,0010 Pas at a shear rate 
of 100 1/s. Also, very large error bars were present in the first few graph points.  
Up-concentrated alginate NPs and mucin 
Alginate NPs with concentration 0,07% w/w and ZnCl2 : alginate ratio 30:70 in 0,05 M NaCl 
were prepared and up-concentrated to 0,20% w/w. After mucin was added to up-concentrated 
NPs, there was no change in the sample observed with the naked eye. Results of the size, PDI 
and ZP measurements are given in table XV. The size of the NPs increased for almost 50 nm, 
the PDI increased from 0,30 to 0,50 and the ZP slightly decreased for 2 mV after up-
concentration. After the addition of mucin to the up-concentrated alginate NPs, the size of the 
measured particles increased for 35 nm, the PDI did not change significantly and the ZP 
increased for 9 mV.  
Table XV – Size, PDI and ZP of three different samples – alginate NPs before up-concentration, 
after up-concentration and up-concentrated alginate NPs (final concentration 0,10% w/w) 




diameter (nm) PDI ZP (mV) 
Alginate NPs before up-concentration (0,07% w/w) 268 0,30 -30 
Alginate NPs after up-concentration (0,20% w/w) 316 0,50 -32 
Up-concentrated alginate NPs (0,10% w/w*) + mucin 
(0,25 % w/w*) 351 0,54 -23 
*final concentrations 
In figure 47 the viscosity curves of 0,07% w/w alginate NPs, up-concentrated alginate NPs 
(0,10% w/w) + mucin (0,25% w/w) and 0,25% w/w mucin in 5 mM phosphate buffer : 0,05M 
NaCl = 1:1 are displayed. They were all flat. The viscosity curve of 0,25% w/w mucin in 5 mM 
phosphate buffer : 0,05M NaCl = 1:1 covered the viscosity curve of 0,07% w/w alginate NPs. 
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The viscosity at a shear rate of 100 1/s was 0,0010 Pas for both samples. The viscosity of the 
sample of up-concentrated alginate NPs (0,10% w/w) + mucin (0,25% w/w) at a shear rate of 
100 1/s was 0,0016 Pas.  
 
Figure 47 – Viscosity curves of 0,07% w/w alginate NPs, up-concentrated alginate NPs (0,10% 
w/w) + mucin (0,25% w/w) and 0,25% w/w mucin in 5 mM phosphate buffer : 0,05M NaCl = 
1:1 
Up-concentrated LM-pectin NPs and mucin 
LM-pectin NPs with the concentration 0,07% w/w and ZnCl2 : LM-pectin ratio 15:85 were 
prepared in 0,05 M NaCl. NPs were up-concentrated to 0,20% w/w. Size, PDI and ZP were 
measured before and after up-concentration. Furthermore, the size, PDI and ZP of up-
concentrated NPs mixed with mucin were measured. Results are given in table XVI. After up-
concentration the size of the NPs increased for approximately 300 nm, the PDI increased from 
0,33 to 0,62 and the ZP decreased from -16 mV to -23 mV. After the addition of the mucin to 
up-concentrated NPs, there was no visible change in the vial. At the other side, there was an 
obvious change in the PDI which increased to 1. The measured size of the particles decreased 
for 300 nm which is not relevant since the PDI is 1 and the biggest particles were probably not 
measured. The ZP remained almost the same after the addition of the mucin.  
Table XVI – Size, PDI and ZP of three different samples – LM-pectin NPs before up-
concentration, after up-concentration and up-concentrated LM-pectin NPs (final concentration 




diameter (nm) PDI ZP (mV) 
LM-pectin NPs before up-concentration (0,07% w/w) 378 0,33 -16 
LM-pectin NPs after up-concentration (0,20% w/w) 694 0,62 -23 
Up-concentrated LM-pectin NPs (0,10% w/w*) + 
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The viscosity curves of the 0,07% w/w LM-pectin NPs, up-concentrated LM-pectin NPs 
(0,10% w/w) + mucin (0,25% w/w) and 0,25% w/w mucin in 5 mM phosphate buffer : 0,05M 
NaCl = 1:1 are displayed in figure 48. Both, viscosity curve of 0,07% w/w LM-pectin NPs and 
0,25% w/w mucin were flat with similar viscosity at a shear rate of 100 1/s: 0,0009 Pas for 
0,07% w/w LM-pectin NPs and 0,0010 Pas for 0,25% w/w mucin. The curve for the sample of 
up-concentrated LM-pectin NPs (0,10% w/w) + mucin (0,25 % w/w) was decreasing slowly 
from 0,0024 Pas at a shear rate of 10 1/s to the final viscosity 0,0017 Pas at a shear rate of 100 
1/s. 
  
Figure 48 – Viscosity curves of 0,07% w/w LM-pectin NPs, up-concentrated LM-pectin NPs 
(0,10% w/w) + mucin (0,25 % w/w) and 0,25 % w/w mucin in 5 mM phosphate buffer : 0,05M 
NaCl = 1:1 
The rheological synergism 
The rheological synergism was calculated for all three types of polysaccharide-based NPs 
(chitosan, alginate and LM-pectin NPs) using an equation 4 already described in chapter 1.7 
(Rheological tests to assess mucoadhesive properties). The results from figure 46, figure 47 and 
figure 48 were used to calculate the values for each curve in order to see if there was a negative, 
positive or zero rheological synergism showing the possible interaction between the NPs and 
mucin. Results of the most up-concentrated chitosan NPs (Chitosan NPs Sample 3) were used 
for the calculation of the rheological synergism for chitosan NPs. The calculated rheological 
synergism curves are shown in figure 49. The rheological synergism values at a shear rate of 
100 1/s were -0,0009 Pas for chitosan NPs and mucin, -0,0004 Pas for alginate NPs and mucin 
and -0,0002 for LM-pectin NPs and mucin. The rheological synergism of LM-pectin NPs was 
positive at low shear rates, then the curve was approaching to 0 Pas and became negative at the 
highest shear rates. Rheological synergism values of alginate NPs and mucin and chitosan NPs 
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Figure 49 – The rheological synergism curves for chitosan NPs and mucin, alginate NPs and 
mucin and LM-pectin and mucin 
Adjusting the viscosity of the nanoparticle dispersion 
First, the viscosity of HEC solutions with three different concentrations (0,5% w/w, 1,0% w/w 
and 1,5% w/w) in 0,05 M NaCl was measured. These results are included and repeated in each 
subchapter together with the results of the viscosity of the samples where HEC was added to 
the different NPs dispersions (chitosan, alginate and LM-pectin NPs) in order to investigate if 
the NPs have any impact on the viscosity of HEC itself. The viscosity curves of the same HEC 
concentration with or without NPs have the same shape of graph points, only the color has been 
changed to white when the NPs are added. In the last subchapter results of the rheological 
experiments on Biotène® are given.  
Adjusting the viscosity of the up-concentrated chitosan NPs 
Chitosan NPs with the concentration 0,05% w/w and TPP : chitosan ratio 15:85 were prepared 
in 0,05M NaCl and up-concentrated to 0,10% w/w. The size, PDI and ZP were measured before 
and after up-concentration (See table XVII). The size of the chitosan NPs increased for less 
than 10 nm, the PDI did not increase significantly and the ZP decreased for 3 mV after the up-
concentration. There was no phase separation or any visible change when HEC was added to 
the NPs. 




diameter (nm) PDI ZP (mV) 
Chitosan NPs before up-
concentration (0,05% w/w) 143 0,14 24 
Chitosan NPs after up-








































The three viscosity curves of different HEC concentrations with the three corresponding 
viscosity curves of the samples where HEC was added to the NPs can be seen in figure 50. In 
addition, the viscosity curve of the 0,05% w/w chitosan NPs was included. The highest viscosity 
was obtained for the sample with the highest concentration of HEC. All the curves decreased 
with increasing shear rates. The viscosity results of the measured samples at shear rate 100 1/s 
can be found in table XVIII. At the shear rates from 0,1 to 1 1/s error bars were larger. Samples 
containing HEC and chitosan NPs had higher viscosity values compared to the samples 
composed only of dissolved HEC at the shear rate above 10 1/s.  
 
Figure 50 – Viscosity curves of 0,05% w/w chitosan NPs; 0,5% w/w HEC; 0,5% w/w HEC + 
0,05% w/w chitosan NPs; 1,0% w/w HEC; 1,0% w/w HEC + 0,05% w/w chitosan NPs; 1,5% 
w/w HEC and 1,5% w/w HEC + 0,05% w/w chitosan NPs 
Table XVIII – The viscosity results of the measured samples (0,05% w/w chitosan NPs, 0,5% 
w/w HEC, 0,5% w/w HEC + 0,05% w/w chitosan NPs, 1,0% w/w HEC, 1,0% w/w HEC + 
0,05% w/w chitosan NPs, 1,5% w/w HEC and 1,5% w/w HEC + 0,05% w/w chitosan NPs) 
Sample Shear rate (1/s) Viscosity (Pas) 
0,05% w/w chitosan NPs 100 0,0008 
0,5% w/w HEC 100 0,0012 
0,5% w/w HEC + 0,05% w/w chitosan NPs 100 0,0015 
1,0% w/w HEC 100 0,0022 
1,0% w/w HEC + 0,05% w/w chitosan NPs 100 0,0025  
1,5% w/w HEC 100 0,0040 
1,5% w/w HEC + 0,05% w/w chitosan NPs 100 0,0044 
4.2.4 Adjusting the viscosity of the up-concentrated alginate NPs 
Alginate NPs with concentration 0,05% w/w and ZnCl2 to alginate ratio 35:65 in 0,05M NaCl 
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below. The size of the NPs increased for approximately 40 nm, PDI increased from 0,27 to 0,36 
and the ZP decreased for 3 mV after the up-concentration. There was no phase separation or 
any visible change when HEC was added to the NPs.  
Table XIX – Size, PDI and ZP of alginate NPs before (0,05% w/w) and after (0,10% w/w) up-
concentration 
 Average hydrodynamic diameter (nm) PDI ZP (mV) 
Alginate NPs before up-
concentration (0,05% w/w) 211 0,27 -30 
Alginate NPs after up-
concentration (0,10% w/w) 249 0,36 -33 
 
In figure 51 the viscosity curves of 0,05% w/w alginate NPs; 0,5% w/w HEC; 0,5% w/w HEC 
+ 0,05% w/w alginate NPs; 1,0% w/w HEC; 1,0% w/w HEC + 0,05% w/w alginate NPs; 1,5% 
w/w HEC and 1,5% w/w HEC + 0,05% w/w alginate NPs are displayed. All the curves 
decreased with increasing shear rates. Samples containing HEC and alginate NPs had higher 
viscosity values compared to the samples composed only of dissolved HEC at the shear rate 
above 10 1/s. The viscosity results of the measured samples at shear rate 100 1/s can be found 
in table XX.  
 
Figure 51 – Viscosity curves of 0,05% w/w alginate NPs; 0,5% w/w HEC; 0,5% w/w HEC + 
0,05% w/w alginate NPs; 1,0% w/w HEC; 1,0% w/w HEC + 0,05% w/w alginate NPs; 1,5% 
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Table XX – The viscosity results of the measured samples (0,05% w/w alginate NPs, 0,5% w/w 
HEC, 0,5% w/w HEC + 0,05% w/w alginate NPs, 1,0% w/w HEC, 1,0% w/w HEC + 0,05% 
w/w alginate NPs, 1,5% w/w HEC and 1,5% w/w HEC + 0,05% w/w alginate NPs) 
Sample Shear rate (1/s) Viscosity (Pas) 
0,05% w/w alginate NPs 100 0,0009  
0,5% w/w HEC 100 0,0012 
0,5% w/w HEC + 0,05% w/w alginate NPs 100 0,0016 
1,0% w/w HEC 100 0,0022 
1,0% w/w HEC + 0,05% w/w alginate NPs 100 0,0027 
1,5% w/w HEC 100 0,0040 
1,5% w/w HEC + 0,05% w/w alginate NPs 100 0,0044 
Adjusting the viscosity of the up-concentrated LM-pectin NPs 
LM-pectin NPs with concentration 0,05% w/w and ZnCl2 to LM-pectin ratio 20:80 were 
prepared in 0,05 M NaCl and then up-concentrated to 0,10% w/w. The size, PDI and ZP results 
are given in table XXI. The size of the LM-pectin NPs increased for more than 1000 nm, the 
PDI increased from 0,28 to almost 1 and the ZP decreased from -16 mV to -20 mV after up-
concentration. 




diameter (nm) PDI ZP (mV) 
LM-pectin NPs before up-concentration 
(0,05% w/w) 330 0,27 -16 
LM-pectin NPs after up-concentration 
(0,10% w/w) 1401 0,98 -20 
 
In figure 52 viscosity curves of 0,05% w/w LM-pectin NPs; 0,5% w/w HEC; 0,5% w/w HEC 
+ 0,05% w/w LM-pectin NPs; 1,0% w/w HEC; 1,0% w/w HEC + 0,05% w/w LM-pectin NPs; 
1,5% w/w HEC and 1,5% w/w HEC + 0,05% w/w LM-pectin NPs can be seen. All the viscosity 
curves were decreasing. Samples containing HEC and LM-pectin NPs had higher viscosity 
values compared to the samples composed only of dissolved HEC at the shear rate above 10 






Figure 52 – Viscosity curves of 0,05% w/w LM-pectin NPs; 0,5% w/w HEC; 0,5% w/w HEC + 
0,05% LM-pectin NPs; 1,0% w/w HEC; 1,0% w/w HEC + 0,05% w/w LM-pectin NPs; 1,5% 
w/w HEC and 1,5% w/w HEC + 0,05% w/w LM-pectin NPs 
Table XXII – The viscosity results of the measured samples (0,05% w/w LM-pectin NPs, 0,5% 
w/w HEC, 0,5% w/w HEC + 0,05% w/w LM-pectin NPs, 1,0% w/w HEC, 1,0% w/w HEC + 
0,05% w/w LM-pectin NPs, 1,5% w/w HEC and 1,5% w/w HEC + 0,05% w/w LM-pectin NPs) 
Sample Shear rate (1/s) Viscosity (Pas) 
0,05% w/w LM-pectin NPs 100 0,0008  
0,5% w/w HEC 100 0,0012 
0,5% w/w HEC + 0,05% w/w LM-pectin NPs 100 0,0020 
1,0% w/w HEC 100 0,0022 
1,0% w/w HEC + 0,05% w/w LM-pectin NPs 100 0,0032 
1,5% w/w HEC 100 0,0040 
1,5% w/w HEC + 0,05% w/w LM-pectin NPs 100 0,0049 
Viscosity curve of Biotène® 
As can be seen in figure 53, the viscosity curve of the commercial product Biotène® is almost 
flat from shear rate 0,1 to 100 1/. Also, the results of different HEC solutions from previous 
subchapters are included in the graph. The viscosity results of the measured samples at shear 
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Figure 53 – The viscosity curve of the commercial product Biotène® and the viscosity curves 
for the samples of three different HEC concentrations (1,5% w/w HEC, 1,0% w/w HEC and 
0,5% w/w HEC) 
Table XXIII – The viscosity results of the measured samples (Biotène®, 0,5% w/w HEC, 1,0% 
w/w HEC and 1,5% w/w HEC) 
Sample Shear rate (1/s) Viscosity (Pas) 
Biotène® 100 0,0100 
0,5% w/w HEC 100 0,0012 
1,0% w/w HEC 100 0,0022 
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In this chapter the obtained results are discussed and evaluated according to the aim of this 
thesis. First, the results from the NPs production, characterization and stability studies are 
discussed. In the second part the interaction of the different polymers and mucin and the 
interaction of the NPs and mucin are assessed. In the last part of this chapter the possibilities of 
adjusting the viscosity of NPs dispersion are explained.  
5.1 Polysaccharide-based nanoparticles preparation and characterization 
There are many different parameters affecting the production of NPs by ionic crosslinking: 1) 
Polymer concentration, 2) solvent properties (ionic strength, pH), 3) crosslinker to polymer 
ratio, 4) mixing and stirring circumstances such as magnet size, speed of peristaltic pump etc., 
5) molecular weight of the polymer (25). In this thesis the polymer concentration and the 
crosslinker to polymer ratio were varied, whereas the other parameters mentioned above were 
constant.  
The solvent used in all samples was 0,05 M NaCl, since it was already reported that the addition 
of a monovalent salt led to smaller and more compact NPs compared to NPs prepared in water 
(24). In pure water, the polymer chains are extended due to the charge repulsion between the 
ionized groups; positively charged amine groups in chitosan and negatively charged carboxyl 
groups in alginate and LM-pectin polymers. After sodium chloride is added, it can screen out 
these charges. Consequently, the electrostatic repulsions are reduced and the polymers become 
more flexible and contracted coils can be formed. It has already been mentioned in chapter 1.5.1 
(Ionic crosslinking) that the polymer concentration must be lower than the overlap 
concentration. To reduce the overlap between the polymer chains, the polymer concentration 
needs to be reduced below the overlap concentration, but also leads to larger total batch volume 
with respect to the same number of NPs produced. Promoting the contraction of the polymers 
in the presence of the monovalent salt leads to reduced chain overlap and to a smaller total batch 
volume required for the same number of NPs which is more optimal for scaling up (24, 25).  
The size, PDI, ZP, turbidity and stability over time were investigated in order to evaluate if the 
prepared NPs were suitable for oral application. It was suggested that a size range of 100 – 500 
nm could be advantageous for NPs intended to be used in the oral cavity, because they might 
mimic the salivary micelle-like structures (21, 45). Samples with monomodal size distribution 
(PDI below 0,3) are desired, since samples with higher PDI are considered as polydisperse and 
are also not suitable for DLS measurements. Considering the ZP, absolute value above 30 mV 
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was proposed to be optimal (38), but also samples with lower absolute ZP value can remain 
stable over a period of time. However, parameters (the size, PDI, ZP) of the samples considered 
as stable, should not change considerably in two weeks. Additionally, the turbidity of the NPs 
measured should be close to 0 cm-1. Increased turbidity tends to be a measure of aggregates or 
sedimentation (23) which are unwanted.  
5.1.1 Alginate nanoparticles 
Both formulations composed of either 0,05% w/w alginate or 0,07% w/w alginate NPs were 
successfully formed and had appropriate properties for the following interaction studies and for 
adjusting the viscosity of the NPs dispersion.  
Pistone et al. already reported that the sample composed of 0,05% w/w alginate and ZnCl2 to 
alginate ratio of 35:65 in 0,05M NaCl had monomodal size distribution, the lowest PDI value 
of the investigated samples and remained stable over a 10 weeks period. The hydrodynamic 
diameter measured was 200 nm, PDI 0,28 and ZP -30 mV (22). Almost the same results were 
obtained in this thesis (figure 18, figure 19). All the measured parameters met the success 
criteria that were set.  
The sample composed of 0,07% w/w alginate and a ZnCl2 to alginate ratio of 30:70 in 0,05M 
NaCl was chosen, since this combination was considered stable over a 40 weeks period in a 
study by Pistone et al. (46). The size, PDI and ZP obtained in this thesis were similar to the 
reported results and met the success criteria that were set. 
5.1.2 LM-pectin nanoparticles  
All the three formulations composed of 0,05% w/w LM-pectin with different ZnCl2 to LM-
pectin ratios of 15:85, 20:80 and 25:75 had PDI higher than 0,3 and were polydisperse (figure 
20). The hydrodynamic diameter was appropriate (approximately 320 – 340 nm) for the 
formulations with ZnCl2 to LM-pectin ratios of 15:85 and 20:80. The latter had better PDI 
(0,36) and was therefore chosen for stability studies. There were no significant differences 
between the ZP in the three formulations (figure 21). The absolute ZP value was rather low 
(approximately -17 mV) which might be the reason for the instability of the NPs. In the 
formulation with a ZnCl2 to LM-pectin ratio 25:75 macroscopic aggregation occurred 
immediately after the preparation and the turbidity increased from 0,01 cm-1 to 0,39 cm-1 (figure 
22).  
Similar results for LM-pectin NPs with the same composition and preparation procedure were 
obtained in a study reported by Pistone et al. However, the PDI was approximately 0,3 for the 
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formulations with ZnCl2 to LM-pectin ratio 15:85 and 20:80, the ZP was -19 mV for 15:85 and 
-17 mV for 20:80. The size of those two formulations reported by Pistone et al. was almost 400 
nm, which is about 60 – 80 nm larger than the size of the NPs with the same composition 
prepared in this thesis. As well the formulation with the ZnCl2 to LM-pectin ratio of 25:75 
reported by Piston et al. led to macroscopic aggregation and the results were not recorded (26).  
Jonassen et al. reported that at a certain amount of Zn2+, adding more Zn2+ did not have a 
positive effect on the size and the PDI. Oppositely, it caused additional crosslinking and 
probably more connections between the particles. This led to bigger aggregates and more 
polydisperse sample (47) and could be the explanation for the macroscopic aggregation in the 
formulation with ZnCl2 to LM-pectin ratio of 25:75.  
The stability of LM-pectin NPs has not been reported before. Jonassen et al. investigated the 
stability of AM-pectin NPs, which were stable for one week of storage, but many aggregated 
flakes were observed in the NPs suspension after one month (47). The size of LM-pectin NPs 
investigated in this thesis increased for approximately 150 nm already after one week, but the 
PDI remained the same (0,36). Similar to AM-pectin NPs, they were not stable after one month 
of storage (figure 23). Low absolute ZP values (figure 24) probably increased the aggregation 
tendency. To increase the stability of the NPs, freeze drying in the presence of a suitable cryo-
protectant has been suggested (47).  
Four formulations composed of 0,07% w/w LM-pectin with a different ZnCl2 to LM-pectin 
ratios were prepared (figure 25, figure 26, figure 27, figure 28). 0,07% w/w LM-pectin NPs 
with a ZnCl2 to LM-pectin ratio 10:90, 20:80 and 25:75 either had too high PDI or NPs were 
too big which both led to high turbidity and/or macroscopic aggregation. The most promising 
ZnCl2 to LM-pectin ratio turned out to be 15:85 and this formulation was already reported by 
Jonassen et al. (47), where the reported PDI was the same as in this thesis (0,50), ZP values 
were similar and NPs reported by Jonassen et al. were approximately 100 nm larger than NPs 
in this thesis.   
None of the LM-pectin NPs formulations prepared in this thesis succeeded the criteria that were 
set. Most of them had PDI higher than 0,50 and absolute ZP values were much lower than 
desired 30 mV. The considerable increase in size (more than 400 nm) and visible aggregation 
already after two weeks in the formulation composed of 0,05% w/w LM-pectin NPs with the 
ZnCl2 to LM-pectin ratio 15:85 only confirmed that LM-pectin is not a suitable polymer for 
preparation of stable NPs able to meet the success criteria.  
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5.1.3 Chitosan nanoparticles 
Three different formulations with chitosan concentration of 0,05% w/w were prepared (figure 
29, figure 30 and figure 31) and can be compared to NPs from a previous study by Pistone et 
al. The size of the NPs with TPP to chitosan ratio 15:85 and 20:80 was almost the same as the 
size of the NPs with the same composition reported in the study. The most significant difference 
between the results already reported by Pistone et al. and this thesis was observed in the 
formulation with the TPP to chitosan ratio 25:75. Macroscopic aggregation and hydrodynamic 
diameter 160 nm were previously reported, whereas in this thesis hydrodynamic diameter was 
only 136 nm and there was no macroscopic aggregation, only the turbidity slightly increased to 
0,04 cm-1 (figure 31). The PDI was similar for all three formulations (0,20 or below). ZP value 
reported in the study was higher for the formulation with TPP to chitosan ratio 15:85 (approx. 
25 mV compared to 20 mV in this thesis), but there was no significant difference between the 
ZP values for 20:80 and 25:75 in the previous study compared to ZP values obtained in this 
thesis (26). In figure 30 a correlation between the TPP to chitosan ratio and the ZP values can 
be seen. When the concentration of TPP is increasing, the positive ZP values are decreasing, 
due to the addition of negatively charged TPP, which neutralizes the positive chitosan charge. 
Since two of the formulations, 15:85 and 20:80, seemed promising, both were chosen for 
stability studies. Better results were expected for the formulation with the TPP to chitosan ratio 
15:85, because the ZP value was higher. As can be seen in figure 32, both formulations 
remained stable over a one-month period. The increase in size was bigger for the formulation 
with TPP to chitosan ratio 20:80, but the difference was too small to ascribe it to the difference 
in the ZP values.  
5.1.4 The most promising formulations 
The most promising formulation among prepared NPs were composed of 0,05% w/w alginate 
or 0,05% w/w chitosan and corresponding crosslinkers. These formulations were stable for at 
least 4 weeks according to the criteria that were set. Parameters used for the preparation of the 
most promising NPs are summarized in table XXIV below. 
Table XXIV – Parameters used for the preparation of the most promising NPs 
Polymer (concentration) Crosslinker* to polymer ratio (w:w) Solvent 
Alginate (0,05% w/w) 35:65 0,05 M NaCl 
Chitosan (0,05% w/w) 15:85 0,05 M NaCl 
Chitosan (0,05% w/w) 20:80 0,05 M NaCl 
*Crosslinker used was ZnCl2 for alginate NPs and TPP for chitosan NPs 
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5.2 Viscosity measurements 
Rheological based interaction studies of different polymers and mucin have been already 
reported (20, 48, 49), but there is no standardized approach to the characterization of such 
interactions. Therefore, it was difficult to compare results obtained in this thesis to previously 
reported studies due to different Mw and types of polymers and varying experimental conditions. 
Investigations of interaction of NPs and mucin by rheology has not been reported in the 
literature before.  
5.2.1 Adjustment of the method 
The method was successfully set up and could be used for the planned interaction studies 
between different polymers or NPs and mucin. The main aim of this experimental part was to 
investigate which concentration and solvents were the most appropriate for further interaction 
studies. Since the concentration of the NPs was quite low 0,05% w/w or 0,07% w/w, 
concentration of the polymer and mucin solutions had to be chosen carefully.  
As expected, alginate solutions showed shear-thinning behavior which was already described 
in chapter 1.7.1 (Viscosity measurements, the theory behind). The viscosity was higher when 
the concentration was higher, because more polymer coils were dissolved in the sample, they 
were closer to each other and could form more entanglements which increased the viscosity 
(figure 34, figure 35). Similar phenomenon was observed when the viscosity of mucin solutions 
with different concentrations were measured (figure 37). The results obtained at the shear rates 
from 0,1 to 10 1/s were not reproducible with three replicates and error bars were large (figure 
34). Therefore, viscosity values measured only at the shear rates from 10 1/s to 100 1/s were 
appropriate for comparison and calculations.   
Not only the concentration of alginate and mucin, but also the solvent had an important 
influence on the viscosity. The viscosity of the same alginate concentration was lower in the 
sample containing alginate dissolved in 0,05 M NaCl compared to the sample containing 
alginate dissolved in 5 mM phosphate buffer (figure 36). This was due to the extended alginate 
chains in phosphate buffer and the contracted alginate chains in 0,05 M NaCl. It was already 
reported by Jonassen et al. that the intrinsic viscosity of chitosan decreased with increasing 
ionic strength of the solution and this was explained by the contraction of the chitosan chains 
due to increased charge screening in the high ionic solution. Furthermore, the intensity of the 
scattered light from the chitosan solution was higher with increasing ionic strength of the 
solvent, which supports the presence of more compact polymer chains in saline solvents (24). 
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The solvent had an important role in the viscosity of the mucin solutions as well. The viscosity 
of the sample with mucin in 0,05 M NaCl was significantly lower than viscosity of the sample 
with mucin in 5 mM phosphate buffer. The viscosity of the sample with mucin in combined 
solvent containing 5 mM phosphate buffer and 0,05 M NaCl with the ratio 1:1 was similar to 
the viscosity of the sample with mucin in 0,05 M NaCl. This suggested that it was appropriate 
to use combined solvent in the further interaction studies where NPs were prepared in 0,05M 
NaCl and mucin was dissolved in 5 mM phosphate buffer which was added to the NPs solution. 
The final solution contained both 0,5 M NaCl and 5 mM phosphate buffer and therefore it was 
easier to compare the measured viscosity values with the values of mucin measured in the 
combined solvent containing 5 mM phosphate buffer : 0,05 M NaCl = 1:1.  
5.2.2 Interaction studies of the different polymers and mucin 
It was reported that in general, when protein and polysaccharide are mixed in a solution, 
attractive or repulsive interactions can be observed. In figure 54 different types of interaction 
are represented. In the case of attractive interactions, the bulk viscosity of the sample is expected 
to decrease due to overall reduction of the hydrodynamic volume of the protein and 
polysaccharides when they are mixed. In some other cases interaction can induce increase in 
viscosity which is higher than the expected sum of the individual contribution (20). 
  
Figure 54 – Schematic representation of the type of interaction between protein and 
polysaccharide, taken from Mackie et al. 
In this thesis attractive interactions were expected to take place when mixing alginate, LM-
pectin or chitosan samples with mucin. More specific, entangled network and increase in 
viscosity were expected for the interaction between LM-pectin or alginate and mucin, because 
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those polymers can interact with positively charged patches in the nonglycosilated regions of 
mucin. At the other side, phase separation due to the precipitation and decrease in viscosity 
were expected for chitosan-mucin samples. Stronger bonds could be formed between positively 
charged chitosan and negatively charged sialic acid as a terminal group of oligosaccharide 
chains.  
It was not possible to see whether there was an interaction between the polymer and mucin from 
the viscosity curves of the polymers, mucin and the mixed polymer and mucin (figure 38, figure 
39 and figure 41). Therefore, the rheological synergism was calculated and used for the 
interpretation of the interaction between the polymers and mucin (figure 42).  
After mucin was added to chitosan, the colour changed from transparent to cloudy in contrast 
to the alginate and LM-pectin sample, where no visible change after addition of mucin was 
observed. This visual observation suggested an interaction between chitosan and mucin. The 
rheological synergism which was calculated confirmed this deduction. There was a significant 
decrease in the viscosity and negative rheological synergism was observed for the sample 
containing chitosan and mucin. Similar results were reported by Rossi et al. (20). They 
examined if the commercial formulation, developed as medical device and named Captomucil®, 
with chitosan concentration ranging between 0,15% and 0,16% w/v was capable of reducing 
the viscosity of a bovine mucin solution in the concentration range 0,5% – 6% w/w. Blank 
samples (mucin or formulation) and mucin-formulation mixture were measured with a 
rotational rheometer at 37 ̊C and the rheological synergism parameter Δη was calculated with 
equation 4. At very low mucin concentration (0,5% – 1% w/w) the results showed positive 
rheological synergism values, whereas at the highest mucin concentration (4% – 6% w/w) 
definite negative rheological synergism values were obtained. It was suggested that the method 
was not sensitive enough at very low concentration, since the values at low mucin concentration 
(0,5% – 2% w/w) and at low shear rates had a high standard deviation. It is difficult to compare 
the results from this thesis to those reported by Rossi et al. due to different concentrations of 
both chitosan and mucin, but there were parallels between negative rheological synergism 
which could confirm the interaction between mucin and chitosan.  
This method was not appropriate to reveal interactions between the alginate or LM-pectin and 
mucin. The values of the rheological synergism were close to 0 Pas. Still, there may be an 
interaction, but it might be that the concentration of the polymers and mucin were not 
appropriate for alginate and LM-pectin. Menchicchi et al. found a correlation between the 
magnitude of interaction and the ability of the polysaccharide coils to contract in the presence 
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of salt. It turned out that alginate with high molecular weight (406 kDa) was more flexible and 
influenced the bulk properties of mucin-alginate mixtures more significantly than alginate with 
low molecular weight (4 kDa). High molecular alginate was more likely to bridge distant sites 
and influenced the conformation of mucin which reduced the overall hydrodynamic volume 
and the viscosity of the mixture (48). Alginate used in this thesis had a molecular weight 147 
kDa which is somewhere in between and due to its flexibility, it might interact with mucin. The 
rheological synergism of mixtures of four different types of pectin (1% w/w) with mucin (5% 
w/w) in three different solvents (stimulated gastric fluid, stimulated intestinal fluid and 
deionized water) was investigated by Thirawong et al. It was reported that in all cases, the 
observed viscosity was higher than the expected viscosity (positive rheological synergism). 
This suggested that the pectins are able to interact with mucin. Furthermore, HM-pectin showed 
a greater interaction with mucin compared to LM-pectin (49). 
5.2.3 Interaction studies of the different NPs and mucin 
Up-concentration was done before the interaction studies were conducted and was successful 
for all three different concentrations of chitosan NPs (chitosan NPs Sample 1, chitosan NPs 
Sample 2 and chitosan NPs Sample 3). In all three samples the PDI remained below 0,3 which 
is the desired value for the NPs (table XIII, table XIV). The hydrodynamic diameter never 
increased more than 50 nm. In contrast to chitosan NPs, PDI was higher than 0,3 for alginate 
NPs (0,50) and LM-pectin NPs (0,62) after up-concentration (table XV, table XVI). Those two 
samples became polydisperse after the up-concentration which suggested possible formation of 
aggregates. The hydrodynamic diameter of alginate NPs increased 48 nm which is acceptable, 
whereas the hydrodynamic diameter of LM-pectin NPs almost doubled after the up-
concentration (NPs grew from initial 378 nm to final 694 nm). That might be correlated with 
the instability of the LM-pectin NPs when measured during a one-month period.  
Visible changes were observed in the samples containing up-concentrated chitosan NPs and 
mucin (figure 43, figure 44 and figure 45). This might be an evidence of an interaction between 
chitosan NPs and mucin. Similar observation was reported by Jonassen where the vial 
containing 0,05% w/w chitosan NPs prepared in 0,05 M NaCl with a TPP to chitosan ratio of 
15:85 mixed with mucin was quite turbid compared to the vials containing chitosan NPs or 
mucin solution. Large flocs/aggregates that started to settle were seen by the naked eye. At the 
same time no significant difference was observed in the mixture of the AM-pectin NPs and 
mucin (25). Moreover, the viscosity measurements (figure 46) also proved the possible 
interaction with mucin in the vial containing the highest concentration of chitosan NPs (0,105 
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% w/w). This sample showed higher viscosity at the lower shear rate, indicating formation of a 
network structure, and lower viscosity at the higher shear rate, when lumps of mucin and 
chitosan NPs were broken down. In the other two vials where the concentration of chitosan NPs 
was 0,05% w/w or 0,085% w/w, the viscosity curve measured was similar as the viscosity curve 
of 0,25% w/w mucin in phosphate buffer : 0,05 M NaCl = 1:1, indicating that mucin chains 
were in excess compared to chitosan NPs. Also, the measured ZP after the addition of the mucin 
to chitosan NPs confirmed that mucin predominated in the vial containing mucin and chitosan 
NPs (0,05% w/w or 0,085% w/w), because it was very close to the ZP measured in the sample 
with mucin (-13 mV), whereas the ZP of chitosan NPs was positive (around 25 mV). The 
rheological synergism that was calculated (figure 49) confirmed strong interaction between 
chitosan NPs and mucin. 
It turned out that alginate NPs also showed negative rheological synergism in contrast to the 
alginate solution, where it was slightly positive and close to 0 Pas. Perhaps soluble complexes 
of alginate and mucin were formed and therefore the viscosity was lower than the sum of each 
component (mucin and alginate NPs).  
Even though the rheological synergism of LM-pectin NPs was not close to 0 Pas compared to 
LM-pectin solution and mucin, it is difficult to predict an interaction between LM-pectin NPs 
and mucin due to the aggregation of NPs that probably happened already after the up-
concentration.  
The method developed in this thesis showed a potential interaction between chitosan and 
alginate NPs and mucin. However, it has some disadvantages. Up-concentration of the NPs 
could potentially influence the results due to aggregation but was still necessary for the viscosity 
measurements. Since it was impossible to measure the viscosity at the shear rates from 0,1 to 
10 1/s due to low concentrations, higher shear rates might also cause disintegration of 
eventually present aggregates. Also, very small deviations in measured viscosity could cause 
large difference in the rheological synergism calculations and be wrongly interpreted as 
interaction with mucin. If NPs could be up-concentrated to a higher concentration (for example 
1% w/w), this method would probably be more appropriate for investigations of the interaction 
with mucin.  
5.2.4 Possibilities of adjusting the viscosity of the nanoparticle dispersion 
The desired viscosity of a final formulation for potential use in dry mouth is ranging from 2 to 
10 mPas. This value was previously reported by Bongaerts et al. who measured the viscosity 
of human whole saliva. The measured viscosity value of human whole saliva was not constant, 
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it was decreasing with increasing shear rate (50). To mimic human saliva, the viscosity needs 
to be in the stated range. HEC was the chosen polymer due to its neutral nature which meant 
less possibilities to interact with the NPs. As reported in the results, only the up-concentration 
of the chitosan NPs was successful, alginate NPs had PDI over 0,3, the size of the LM-pectin 
NPs increased for more than 1000 nm and PDI was almost 1. However, all the up-concentrated 
NPs were used in the further experiments to investigate the possibilities of the adjusting the 
viscosity. It turned out that NPs significantly contribute to the viscosity of the HEC solutions. 
When the HEC concentration was 0,5% w/w, the contribution of the NPs was larger compared 
to the sample where the HEC concentration was 1,5% w/w. When the concentration of HEC 
was higher, the contribution from the interaction between NPs and HEC to the viscosity was 
negligible, because the number of HEC chains was so high that NPs were lost among HEC 
chains.  
It was possible to adjust the viscosity of the chitosan and alginate nanoparticle dispersions with 
HEC. Final viscosity values of the NPs mixed with HEC (1% w/w or 1,5% w/w) ranged from 
2 mPas to 5 mPas, which was in accordance with the reported viscosity value of the whole 
human saliva. Also, the viscosity values were decreasing with increasing shear rate. The 
viscosity curve of the commercial product Biotène® that is already used in xerostomia patients 
showed that even higher shear rate did not have an influence on its stable viscosity value which 
was 10 mPas (figure 53). This commercial product is a mixture of different polymers and other 
ingredients water, glycerin, xylitol, sorbitol, propylene glycol, poloxamer 407, sodium 
benzoate, HEC, methylparaben, propylparaben, aroma, sodium phosphate and disodium 
phosphate. Exact concentration of HEC or any other ingredient was not stated and therefore it 




This study has shown that: 
1) Alginate, chitosan and LM-pectin NPs were prepared by ionic crosslinking. Alginate and 
chitosan NPs were stable over a period of one month with only small changes in the particles 
size, whereas LM-pectin NPs did not remain stable. The most promising formulations were: 
a) alginate = 0,05% w/w, ZnCl2 : alginate ratio = 35:65; b) chitosan = 0,05% w/w, TPP-
chitosan ratio = 15:85 or 20:80, solvent = 0,05 M NaCl. 
2) The rheological method was successfully set up and used for investigating the interaction 
between the polymers and mucin and the NPs and mucin. Negative rheological synergism 
was observed between chitosan and mucin, whereas the interaction between alginate or LM-
pectin and mucin was not verified. The most promising interaction was observed between 
up-concentrated chitosan NPs and mucin. Namely, negative rheological synergism was 
measured and precipitation was observed with the naked eye. Alginate NPs also showed 
negative rheological synergism. It was impossible to verify a potential interaction between 
LM-pectin NPs and mucin due to the aggregation of the NPs that probably happened already 
after up-concentration.  
3) It was possible to adjust the viscosity of the chitosan and alginate nanoparticle dispersions 
with HEC. Final viscosity values of the NPs mixed with HEC (1% w/w or 1,5% w/w) ranged 
from 2 mPas to 5 mPas, which was in accordance with the reported viscosity value of the 
whole human saliva (2 mPas to 10 mPas).  
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